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ABSTRACT
Algorithms and Tools for in silico Design of Cell Factories
The progressive shift from chemical to biotechnological processes is one
of the pillars of the 21st century industrial biotechnology. Projections from
the Organization for Economic Co-operation and Development estimate
that, within the next two decades, about 35% of the production of chemi-
cals will be guaranteed by biotechnological processes. The development of
efficient cell-factories, capable of outperforming current chemical processes,
is vital for this leap to happen. The development of constraint-based models
of metabolism and rational computational strain optimization algorithms
(CSOMs) hold the promise to accelerate these efforts.
Here, we aim to provide an in depth and critical review of the currently
available constraint-based CSOMs, their strengths and limitations, as well
as to discuss future trends in the field. Then, we cover in detail the main
tasks in strain design and provide a taxonomy of the main CSOMs. These
are presented in detail and their features and limitations are explored.
One of the identified problems is their limited offering of trade-off solu-
tions of biotechnological objectives (e.g. overproducing desired compounds
or minimizing the cost of solutions) versus cellular objectives (e.g. max-
imizing biomass). To tackle this problem we developed an evolutionary
multi-objective (MO) framework for strain optimization capable of finding
vii
high-quality, trade-off solutions that can be explored by metabolic engineer-
ing experts.
Also, the majority of the strain optimization algorithms rely on phe-
notype prediction methods based on debatable biological assumptions. We
verified that, for a large percentage of solutions generated by a CSOM using
one phenotype prediction method, the results would not hold when simu-
lated with an alternative method. Leveraging on the previously developed
framework and driven by the MO nature of this problem, we proposed a
tandem approach capable of finding strain designs that comply with the
assumptions of distinct phenotype prediction methods, validating the ap-
proach with multiple case studies.
Finally, all the algorithms developed during this work are made available
in the form of an open and flexible software framework. This framework is
a powerful tool for both common users, interested in exploring the available
methods, and experienced programmers which are able to easily extend it
to support new features.
viii
RESUMO
Algorithms and Tools for in silico Design of Cell Factories
A conversa˜o de processos qu´ımicos em processos biotecnolo´gicos e´ um
dos grandes objetivos da biotecnologia industrial para o se´culo XXI. A Or-
ganizac¸a˜o para a Cooperac¸a˜o e Desenvolvimento Econo´mico estima que, nas
pro´ximas duas de´cadas, cerca de 35% da produc¸a˜o de compostos qu´ımicos
sejam assegurados por processos biotecnolo´gicos. O desenvolvimento de
fa´bricas celulares eficientes, capazes de superar o rendimento dos atuais
processos qu´ımicos, e´ vital para que este avanc¸o seja poss´ıvel. O desen-
volvimento de modelos metabo´licos e algoritmos para otimizac¸a˜o de estirpes
(AOEs), e´ uma das grandes esperanc¸as para acelerar estes esforc¸os.
Neste trabalho, pretendemos efetuar uma revisa˜o aprofundada dos AOEs
atuais baseados na modelac¸a˜o por restric¸o˜es, analisar os seus pontes fortes
e limitac¸o˜es, e discutir temas de interesse futuro na a´rea. De seguida, estu-
damos em detalhe os tipos de estrate´gias comuns para o desenho de estirpes
e formulamos uma taxonomia para os principais AOEs. Estes sa˜o avaliados
em detalhe e as suas caracter´ısticas principais sa˜o devidamente exploradas.
Um dos problemas identificados prende-se com a sua oferta limitada
de soluc¸o˜es de compromisso entre objetivos industriais (como produzir em
excesso um composto de interesse, ou reduzir o custo de implementar uma
soluc¸a˜o) e objetivos celulares (como a maximizac¸a˜o do crescimento). Para
ix
enfrentar este problema, desenvolvemos uma plataforma para otimizac¸a˜o
de estirpes baseada em computac¸a˜o evoluciona´ria multiobjetivo, capaz de
encontrar soluc¸o˜es de compromisso de elevada qualidade, que podem ser
exploradas por peritos em engenharia metabo´lica.
Para ale´m disso, a grande maioria dos AOEs baseia-se em me´todos de
previsa˜o de feno´tipos que, por sua vez, sa˜o constru´ıdos sobre assunc¸o˜es
biolo´gicas discut´ıveis. Verificamos que uma grande percentagem das soluc¸o˜es
geradas por um AOE, usando um me´todo de previsa˜o de feno´tipos, deixaria
de ser va´lida quando simulada com um me´todo alternativo. Tirando partido
da plataforma desenvolvida anteriormente e motivados pela natureza mul-
tiobjetivo deste problema, propusemos uma abordagem capaz de encontrar
estirpes que respeitassem as assunc¸o˜es de diferentes me´todos de previsa˜o de
feno´tipos. Esta abordagem foi validada com va´rios casos de estudo.
Por fim, todos os algoritmos desenvolvidos ao longo deste trabalho sa˜o
disponibilizados sob a forma de uma aplicac¸a˜o de software aberto. Esta
constitui uma ferramenta poderosa, tanto para utilizadores comuns interes-
sados em explorar os me´todos disponibilizados, como para programadores
experientes que podem estendeˆ-la facilmente com novos me´todos.
x
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INTRODUCTION
In the context of Metabolic Engineering (ME), Computational Strain Op-
timization Methods (CSOMs) deal with the problem of finding optimal
modifications to an organisms’ genotype, to promote the overproduction of
compounds of interest and minimize the excretion of undesired by-products.
This thesis is focused on the analysis of existing CSOMs and in the design
and implementation of alternatives to the current metaheuristic CSOMs.
All the tools developed during this work are made available to the ME
community in an accessible and extensible framework.
This chapter provides an introduction to this work, addressing its mo-
tivation, highlighting the main objectives and presenting the structure of
this text.
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1.1 Context and Motivation
The concept of metabolic pathway manipulation towards desirable behav-
ior is not new. Early methods relied mostly on the use of mutagenesis
and strain selection techniques, with notable examples coming from the
production of aminoacids, vitamins or antibiotics [1]. However, with the
increasingly demanding industrial requirements, the need to resort to more
rational approaches became evident. The development of genetic engineer-
ing brought ways to more precisely modify specific genes/enzymes, thus
paving the way towards the more rational introduction of direct genetic
changes to create desirable strains [2].
Moreover, the recent advances in genome sequencing technologies which
culminated in the development of next generation sequencing technolo-
gies [3] and semi-automated annotation techniques, made the availability of
a large number of fully annotated microbial genomes a reality. This informa-
tion explosion also accelerated the development of genome-scale metabolic
models (GSMMs) for a large number of organisms [4]. The development
of phenotype prediction methods supporting distinct genetic and environ-
mental conditions, including the well-known method of Flux Balance Anal-
ysis [5–7], combined with GSMMs, brought powerful tools to predict the
behavior of microbial strains and support rational ME efforts.
Backed by these efforts, the development of strain design methods, where
bioengineering objectives could be rationally addressed, became paramount.
In 2003, Burgard and co-workers released OptKnock [8], which would be-
come the basis for a large portion of the constraint-based strain design
methods for the following decade. Such in silico ME approaches are able
to propose genetic changes based on computational simulation and mathe-
matical optimization methods. While these approaches have provided good
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results, they are still limited since they usually return a single solution to
the problem or, in some cases, sets of solutions with limited variability.
Among all, meta-heuristic CSOMs [9] provide the most diverse solutions,
but typically those follow similar strategies to maximize the selected ob-
jective function. To overcome these limitations, information from multiple
criteria is often included in a single objective function, which can introduce
undesired biases in the sampling process.
An analysis of available CSOMs, reveals several shortcomings of the cur-
rent methods. As an example, defining an objective function for a CSOM
can be a difficult task. Because of this, and since models lack critical infor-
mation to improve the quality of the predictions, the solutions proposed by
most CSOMs are not only overly-optimistic, but sometimes physiologically
impossible. Multi-objective (MO) approaches search for optimal trade-offs
of solutions instead of a single optimal solution, thus providing a valuable
tool for expert researchers, allowing them to opt for compromise solutions
believed to have better chances of working in vivo.
1.2 Research Aims
In this context, the aim of this work will be to develop novel CSOMs, based
on an MO perspective, using algorithms with given proofs from Evolution-
ary Computation, which can improve the current state of the art methods
finding competitive and robust designs, and providing open computational
tools for the ME community.
With this overall aim in mind, several scientific/technological objectives
have been defined for this work:
• To conduct a comprehensive analysis on the currently available CSOMs
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and related literature, highlighting their main similarities and differ-
ences, as well as their strengths and limitations, also proposing a new
classification system for the different types of CSOMs;
• Aggregate and analyze successful applications of CSOMs in real-world
case studies and discuss their relevance in a future bio-based economy;
• Suggest and implement new approaches for strain optimization. These
will tackle some of the major problems identified in other CSOMs:
– addressing their limited offering of trade-off solutions of biotech-
nological objectives (e.g. overproducing desired compounds or
minimizing the cost of solutions) versus cellular objectives (e.g.
maximizing biomass) through an evolutionary-based MO ap-
proach;
– addressing their over-dependency on the biological assumptions
of their inner phenotype prediction methods through tandem
strain optimization techniques.
• Integrate the developed packages into the OptFlux suite [10], a soft-
ware workbench for ME that includes a straightforward graphical user
interface, developed by the research group where this work was inte-
grated.
1.3 Outline of the Thesis
This manuscript has been structured in six chapters addressing all of the
previously stated aims.
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The thesis begins in the current chapter (Chapter 1) with a general
introduction, together with the statement of the proposed aims and an
outline of the manuscript’s structure.
In Chapter 2, an extensive literature review, covering the main CSOMs,
and evidencing both their similarities and differences is presented. Further-
more, a classification for these methods is suggested and their successes
and limitations are discussed. We close with a discussion around the fu-
ture challenges of ME and strain design and its relevance for a sustained
bio-based economy over the coming years.
One of the main contributions of this work is introduced in Chapter 3,
where a new evolutionary multi-objective framework for strain optimization
(MOStrain) is proposed. A thorough comparison of results between this
method and previous meta-heuristic CSOMs is performed, and a critical
analysis of some solutions is presented.
Leveraging on the framework developed in Chapter 3, a new tandem
strain optimization approach, capable of finding strain designs compliant
with multiple phenotype prediction methods is proposed in Chapter 4.
This new method is tested for a panoply of case studies, and its ability to
find robust strain designs, in situations where previous methods displayed
limitations, is evidenced.
In Chapter 5, all the software tools developed during this thesis are ex-
plained in detail. These tools are made available in a powerful yet accessible
framework, for the ME community to use and extend.
Finally, in Chapter 6, the main conclusions are drawn, and topics for
future work are suggested.
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IN SILICO CONSTRAINT-BASED STRAIN
OPTIMIZATION METHODS: THE QUEST FOR
OPTIMAL CELL FACTORIES
Shifting from chemical to biotechnological processes is one of the corner-
stones of the 21st century industry. The production of a great range of
chemicals via biotechnological means is a key challenge towards a biobased
economy. However, this shift is occurring at a pace slower than initially
expected. The development of efficient cell-factories that allow for compet-
itive production yields is of paramount importance for this leap to happen.
Constraint-based models of metabolism, together with in silico strain design
algorithms promise to reveal insights into the best genetic design strategies,
a step further to achieve that goal. In this work, a thorough analysis of the
main in silico constraint-based strain design strategies and algorithms is
performed, their application in real-world case studies is analyzed and a
path for the future is preconized.
9
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2.1 Introduction
Since the early 1970s, modern Biotechnology has started to emerge as a
competitor of the chemical industry towards the production of valuable
chemicals, although it remains until today in a great disadvantage. How-
ever, the scenario is rapidly changing given the increasing need for sus-
tainable manufacturing processes. This has given industrial biotechnology
a new breath, boosting its use in the production of a number of valuable
products, such as pharmaceuticals, fuels and food ingredients. The Organi-
zation for Economic Co-operation and Development (OECD) predicts that
by 2030, 35% of chemicals and other industrial products will be largely
supported by industrial biotechnology [1].
Of course, mankind has been using microbes as a way to produce food
ingredients and other valuable products since the Neolithic age. However,
the ability to manipulate genomes has provided the field with novel pow-
erful tools. Indeed, the development of industrial biotechnology is deeply
intertwined with the recent evolution of molecular biology and genomics
technologies.
Among these advances, two must be emphasized given their relevance
to the field. In the early 1970s, the development of recombinant DNA
technology [2–4] fostered the efforts in genetic engineering and, eventually,
gave rise to modern biotechnology. A few years later, in the mid 1970s,
the development of the Sanger sequencing technique [5, 6] provided another
boost, starting a real revolution on genome sequencing technologies. Indeed,
the first automated sequencer was developed in the late 1980s and, in 1995,
the first complete genome of a microbe, Haemophilus influenza, was finished
and published [7], followed by many others.
The importance of these technologies for industry is due to an obvious
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observation: since microbes have evolved according to their own intrinsic
objectives, in order to comply with industrial purposes, their metabolism
needs to be retrofitted. Indeed, a sustainable, environmental-friendly and
economically viable bio-based industry requires the use of cell factories tai-
lored to deliver near-optimal yields of substrate to product conversion, as
well as high titers and productivities.
The concept of metabolic pathway manipulation towards desirable be-
havior is an old one, with notable examples coming from the production of
aminoacids, vitamins or antibiotics [8]. These early methods relied mostly
on the use of mutagenesis and creative strain selection techniques. As these
traditional approaches for microbial improvement started to struggle to keep
up with industrial requirements, resorting to more rational approaches be-
came a need. Genetic engineering provides the way to more precisely mod-
ify specific genes/ enzymes, thus paving the way towards the more rational
introduction of direct genetic changes to create desirable strains [9].
In 1991, Bailey coined the term “Metabolic Engineering” (ME) as the
use of recombinant DNA technology for the purpose of improving cellular
activities via manipulation of enzymatic, transport and regulatory functions
of the cell [10]. In contrast with previous experiences in genetic engineer-
ing, he preconized a much more direct, target-oriented and mechanistic
approach. ME was also more attractive to the industry and less reluctant
towards parallel sciences such as systems biology. In fact, it was thought
from the beginning to embrace transversal knowledge.
The remarkable advances on genome sequencing technologies have played
a decisive role for the change of perception regarding the genotype-phenotype
relationship, which, at the time, was still mostly treated based on qualitative
analysis. With the recent developments in genome sequencing technologies,
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culminated by the surge of the so-called next generation sequencing tech-
nologies [11], as well as semi-automated annotation techniques, an increas-
ingly large number of fully annotated microbial genomes are being made
available.
These full genome sequences provide comprehensive information about
the genetic elements that compose an organism and, when combined with
the understanding of cellular processes such as metabolism, results in struc-
tured knowledge that can be mathematically represented. This knowledge
explosion accelerated the development of genome-scale metabolic models
(GSMMs) for a large number of organisms [12].
While a number of attempts have been made to model the whole cell
behavior within the realm of systems biology research [13], these models are
typically incomplete due to the lack of kinetic and regulatory information.
An alternative is provided by the field of constraint-based modeling (CBM),
which has been applied to the analysis of biochemical reaction networks for
over 25 years [14]. One of the major outcomes of CBM research has been the
development of phenotype prediction methods supporting distinct genetic
and environmental conditions including the well-known method of Flux
Balance Analysis [15–17]. When combined with GSMMs, these methods
provide powerful tools to predict the behavior of microbial strains and,
thus, support rational ME efforts.
Based on these efforts, the time for the development of strain design
methods had come, where bioengineering objectives could be rationally ad-
dressed. In 2003, Burgard and co-workers released OptKnock [18], which
would become the basis for a large portion of the constraint-based strain
design methods for the following decade. Such in silico ME approaches are
able to propose genetic changes (gene deletions in the case of OptKnock)
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based on computational simulation and mathematical optimization meth-
ods. In this way, they are able to speed up the process of strain design, by
reducing the time in the lab, and making more effective the engineering of
microbes.
However, while this last decade has witnessed a rapid proliferation of
strain optimization methods, mostly based on CBM approaches, in vivo
proofs-of-concept are lagging far behind, as well as rigorous analysis of the
predicting power of both simulation and design methods. Moreover, the
concomitant proliferation of available GSMMs, often of organisms poorly
characterized in physiological terms, adds a new layer of uncertainty to in
silico predictions that also needs to be considered when designing novel and
improved strains.
Here, we aim to provide an in depth and critical review of the currently
available CBM-based strain optimization methods, their strengths and lim-
itations, as well as to discuss future trends in the field. The importance
of these methods for ME, and their relevance to boost modern industrial
biotechnology efforts will be discussed, as well as the need for large-scale in
vivo validation of rational design-related methods.
In the remaining, we start by putting forward the main concepts and
methods within CBM, which will serve as a context and support for the
strain optimization methods. Then, we cover in detail the main tasks in
strain design and provide a taxonomy of the main strain optimization meth-
ods. These are presented in detail, their features and limitations are ex-
plored and the connections among different methods are highlighted. The
section closes with a global discussion on the merits and limitations of the
methods.
The review follows with an overview of selected practical applications
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of strain design, in general, and of the contribution of the reviewed opti-
mization methods in particular, focusing on experimentally and industrially
validated applications. Successes and limitations of the approaches are dis-
cussed. We close with a discussion around the future challenges of ME and
strain design and its relevance for a sustained bio-based economy over the
coming years.
2.2 Constraint-based Modeling: Concepts
and Methods
2.2.1 Constraint-based Models
Cellular functions are dependent on a series of intertwined mechanisms,
such as metabolism or transcriptional regulation, which can be affected
by a multitude of factors. Understanding the relationships between these
mechanisms and the environment is key to developing correct and predictive
models. Based on biochemical knowledge, classical kinetic models provide
detailed dynamical and quantitative descriptions of the systems. However,
they depend on many, usually difficult to measure, parameters and are also
computationally expensive to solve in the genome-scale context [19]. Indeed,
up to this date there are no dynamic genome-scale models of metabolism
that can be used effectively in ME efforts, mainly given the difficulty in
obtaining the relevant kinetic data [20, 21]. For several metabolic net-
work analysis or metabolic engineering tasks, a simpler approach might be
sufficient to reach useful results. For these purposes, certain realistic as-
sumptions can be adopted, avoiding the burden of determining kinetic rate
equations and their parameters [19].
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Since the metabolic transients are usually faster than both microbial
growth rates and dynamic environmental changes, the internal metabolite
concentrations can often be assumed to be in a quasi-steady state. This as-
sumption is at the core of constraint-based metabolic modeling approaches
and its derived consequence is that all the metabolic fluxes leading to forma-
tion or degradation of any intracellular metabolite are mass-balanced [22].
This assumption can be represented in the form:
S.v = 0 (2.1)
where S is an m × n matrix of stoichiometric coefficients, for a set of m
metabolites and a set of n reactions, and v is the vector of n reaction
rates (fluxes) Figure (2.1,b). For each reaction, maximum and minimum
flux values can also be imposed to define the thermodynamic feasibility
(directionality) and flux capacity of the reactions, i.e.:
0 ≤ vi ≤ βi, ∀i ∈ Nirrevαi ≤ vi ≤ βi,∀i ∈ Nrev (2.2)
where vi is the flux carried over reaction i, Nrev and Nirrev are subsets of
N , composed by all reversible and irreversible reactions, respectively and
αi and βi are the lower and upper bound for the flux over reaction i. For
most GSMMs, the number of reactions surpasses the number of compounds,
therefore there are more variables than equations in the system defined by
Equation 2.1.
Further details, such as translational/transcriptional knowledge in the
form of Gene-Protein-Reaction (GPR) associations are also typically in-
cluded in the models [23]. This additional knowledge enables the develop-
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ment of more realistic phenotype prediction and strain design methods. The
representation of GPR associations usually resorts to Boolean logic, where
the relationships between reactions and their encoding genes are modeled
as logical AND/OR operations, representing for instance cases of protein
complexes and iso-enzymes. This allows, for instance, to determine the
reactions inactivated after a set of gene deletions Figure (2.1,c).
Parallel efforts focused on the use of Boolean approaches to represent
models of transcriptional regulation. By considering that each node in the
network is in a binary state (active/inactive), Boolean networks try to ap-
proximate the dynamics of regulatory systems. For each node, a Boolean
update rule is defined which depends on the values of other nodes. Notable
applications of Boolean networks include the elucidation of regulatory inter-
actions by Kaufmann [17, 24] and the simulation of a system behavior under
various genetic/environmental conditions by Li [25]. Despite the known fact
that the expression of metabolic genes is affected by a plethora of different
stimuli through regulatory mechanisms, few studies have focused on the in-
tegration of these approaches into GSMMs. The main efforts have been the
inclusion of transcriptional regulation Boolean constraints, first by Covert
and collaborators over an E. coli GSMM [26] and more recently and in a
more general purpose way in the TIGER framework [27], as well as the in-
clusion of the transcriptional and translational machinery into the GSMMs
of E. coli by Thiele et al [28].
Reconstruction of GSMMs has skyrocketed in the last decade, with
dozens of these models currently available, for organisms from all the do-
mains of life including recent efforts to model complex eukaryotes as is the
case with the human models. In Table 2.1, a collection of some publicly
available reconstructions is presented aiming to portray the main efforts,
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rather than to be an exhaustive recollection. It is noticeable that for the
most studied organisms, as E. coli or S. cerevisiae, a large number of mod-
els have been proposed for more than a decade now, generating models
that are constantly growing in the level of biological detail covered. When
used in tandem with phenotype prediction and strain design methods, to
be covered next, GSMMs are a powerful tool to aid in various metabolic
engineering tasks [29].
Table 2.1: Some publicly available GSMMs. Domain: E - Eukarya, B - Bacteria, A -
Archaea. Reconstruction data includes number of reconstructions (#), maximum number
of functionally annotated genes (G), metabolites (M) and reactions (R).
Classification Reconstruction data
Ref
Organism Domain Dates # IDs G M R
A. thaliana E 2010 1 AraGEM 1419 1748 1567 [30]
A. niger E 2008 1 iMA871 871 1045 1190 [31]
B. subtilis B
2007
2009
2
iYO844
1103 1138 1437
[32]
[33]iBsu1103
C. reinhardtii E 2011 1 iRC1080 1080 1068 2190 [34]
C. salexigens B 2011 1 iOA584 584 1411 1386 [35]
C. beijerinckii B 2011 1 iCB925 925 881 938 [36]
C. thermocellum B 2010 1 iSR432 432 525 577 [37]
D. ethenogenes B 2010 1 iAI549 549 549 518 [38]
D. shibae B 2013 1 iDsh827 827 1614 1488 [39]
E. coli B
2000
↓
2011
5
iJE660
1366 1136 2251
[40]
[23]
[41]
[42]
[43]
iJR904
iAF1260
iJO1366
iCA1273
G. sulfurreducens B 2006 1 iRM588 588 541 523 [44]
H. influenza B
1999
2000
2
iJE296
400 451 461
[7]
[45]iCS400
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H. pylori B
2002
2005
2
iCS291
391 485 476
[46]
[47]iIT341
H. sapiens E
2007
2013
2
Recon 1
1789 2626 7440
[48]
[49]Recon 2
K. pneumoniae B 2011 1 iYL1228 1228 1658 1970 [50]
M. acetivorans A
2011
2012
2
iVS941
941 715 756
[51]
[52]iMB745
M. barkeri A
2006
2013
2
iAF692
746 719 741
[53]
[54]iMG746
M. musculus E
2005
↓
2010
4 iMM1415 1415 2774 3726
[55]
[56]
[57]
[58]
M. tuberculosis B
2007
↓
2010
3
iNJ661
726 838 1049
[59]
[60]
[61]
GSMN-TB
iNJ661m
M. genitalium B 2009 1 iPS189 189 274 262 [62]
P. pastoris E
2010
2012
2
iPP668
915 899 1423
[63]
[64]iLC915
P. putida B
2008
↓
2010
3
iNJ746
900 1044 1071
[65]
[66]
[67]
iJP815
PpuMBEL1071
P. aeruginosa B 2008 1 iMO1056 1056 760 883 [68]
R. eutropha B 2007 1 RehMBEL1391 1256 1391 1171 [69]
S. cerevisiae E
2003
↓
2013
14
iFF708
977 2056 3334
[70]
[71]
[72]
[73]
[74]
[75]
[76]
[77]
[78]
iND750
iLL672
iIN800
iMH805/775
Yeast[2-7]
iMM904
iAZ900
iTO977
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S. typhimurium B
2009
↓
2011
3
iRR1083
1270 1119 2201
[79]
[80]
[81]
iMA945
STM v1.0
Z. mobilis B
2010
2011
2
ZmobMBEL601
363 704 747
[82]
[83]iZM363
2.2.2 Constraint-based Phenotype Prediction
Phenotypic behavior can be predicted using a number of constraint-based
approaches over the information kept in metabolic models. The intersection
of the available biological constraints (e.g. steady-state, reversibility, flux
capacity) defines the flux cone of admissible flux distributions [84] (Figure
2.2,a), representing the underdetermination of the system. Given that ex-
perimental measurements of internal fluxes are difficult to obtain, the usual
approach to solve this underdetermined system is to transform it into an
optimization problem (Figure 2.2,b). For this purpose, biological assump-
tions are usually adopted in the form of an objective function. One common
approach is to rely on the rationale that organisms might have been evolu-
tionarily shaped towards metabolic operations that favor particular objec-
tives. Extra constraints are commonly employed by many methods, which
further constraint the flux cone, redirecting the flux towards a desirable
state (Figure 2.2,c).
In Flux Balance Analysis (FBA) [15–17], these assumptions are modeled
using linear objective functions, usually maximizing a given reaction rate
(flux), minimizing the global energy expenditures of the cell, or a panoply
of other ones [85]. With a linear objective function subjected to linear
constraints, the problem is conveniently translated into a readily solvable
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Figure 2.1: Diagram of the various components commonly found in constraint-based
metabolic (and integrated metabolic/regulatory) genome-scale models. The example in-
cludes a) - a toy network composed by 10 reactions, 6 metabolites, 8 genes and 2 tran-
scription factors; b) - the corresponding stoichiometric matrix; and c) - the corresponding
gene-protein-reaction and transcriptional regulation rules.
linear programming (LP) problem. The most commonly used assumption
is that microorganisms are evolutionarily adapted to maximize growth [86–
88], which is modeled as a linear objective function (an artificially defined
flux) that maximizes biomass formation.
Despite its utility, classical FBA is still fairly limited due to its obliv-
iousness of several biological phenomena. As an example, the effects of
regulatory constraints under certain media/environmental conditions are
not accounted for. For this purpose, specialized methods such as regula-
tory FBA (rFBA) [89] or steady-state regulatory FBA (SR-FBA) [90] have
been developed. Both methods rely on additional information, such as
transcriptional regulation constraints [26], being integrated in the models.
Regulatory FBA forecasts dynamic flux profiles in changing environ-
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ments by predicting a regulatory and a metabolic steady state for short
successive time intervals, while ensuring consistency with the previous state
in each step. Alternatively, SR-FBA simulates an ensemble metabolic-
regulatory steady state under the assumption of maximal biomass produc-
tion rate, which satisfies both metabolic and regulatory constraints. A
mixed-integer linear programming problem (MILP) is yielded by the super-
imposition of the regulatory constraints and GPRs as linear functions in
the model.
While the assumption of maximal growth is acceptable under natural
conditions (wild-type), the same is heavily disputed when the organism is
subjected to genetic perturbations, for instance when simulating the pheno-
type of gene deletion mutant strains. To account for the burden of shifting
from one operating region to another, Segre` and co-workers introduced the
Minimization of Metabolic Adjustment (MOMA) [86]. Contrarily to FBA,
MOMA is not growth-coupled, meaning that the optimal flux distribution
for a given set of conditions is not assumed to be dependent on the maxi-
mization of the organism’s biomass production rate. Instead, it minimizes
the sum of the squared differences between the wild type (typically calcu-
lated with FBA or given as a reference flux distribution) and the mutant flux
distributions, thus defining a quadratic objective function, which translates
into a convex quadratic optimization problem (QP) with linear constraints.
Linear MOMA (LMOMA), an alternative linear implementation of MOMA
was later proposed by Becker [91], which removes the burden of the quadratic
approach, by replacing the original objective function by a linear one, using
the minimization of the sum of the absolute values of differences (between
the a reference flux distribution and the mutant).
With a similar purpose, Shlomi and co-workers developed the regulatory
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on/off minimization (ROOM) [92] algorithm that minimizes the number of
significantly changed fluxes, relative to the original flux distribution, after
genetic perturbations. This approach requires the introduction of binary
variables in the objective function, thus converting the LP problem into a
MILP one, increasing its complexity. Both MOMA and ROOM formula-
tions rely on the assumption that, after genetic perturbations, the organ-
ism’s metabolic and regulatory responses favor a new steady-state close to
the original operating region, rather than maximizing cellular growth.
More recently, Brochado and co-workers developed the Minimization of
Metabolites Balance (MiMBl) [93] as an alternative to MOMA, aiming at
addressing some of its limitations. Instead of tackling the problem by opti-
mizing fluxes, MiMBl resorts to metabolite turnovers (the sum of all fluxes
producing or consuming it, multiplied by the corresponding stoichiometric
coefficients), thus eliminating problems related with the sensitivity of the
solutions to the stoichiometric representations, which can greatly affect the
phenotype predictions.
The previous methods, and more notably FBA, have an important lim-
itation, since while they provide a solution with a unique optimal value for
the objective function, a large number of flux distributions may exist that
lead to this value, i.e. multiple optima may exist. One way to address this
issue was proposed by the Parsimonious enzyme usage FBA method which
assumes that, under growth pressure, the strains that process the growth
rate more efficiently (with minimum enzyme usage) will have a competitive
advantage [94]. This method mimics this assumption by choosing, from
these multiple optima, the flux distribution that minimizes the sum of all
the fluxes in the model. A two-step approach is frequently used to approx-
imate this formulation, where a second LP that minimizes the sum of all
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fluxes while keeping the biomass flux at an optimum level, is performed [95].
Flux Variability Analysis (FVA) [96] provides a distinct approach that
aims to characterize the space of possible variation of specific fluxes, given
a set of constraints. It can be used to define tight bounds for the fluxes
in a GSMM if no further constraints are defined, or to check the possible
variation of a given flux in optimal or sub-optimal solutions, if a constraint
over the objective function is defined. For instance, FVA is quite useful in
checking if a flux can vary in optimal FBA solutions, by setting a constraint
that requires the biomass flux to be equal to its optimal value. Among other
applications, FVA is used to assess the robustness of a flux distribution, for
instance in a mutant strain simulation, regarding its production capability
of a certain compound. FVA is typically applied to a given reaction flux by
solving a pair of LP problems that maximize and minimize the target flux,
obeying the set of defined constraints.
2.2.3 Unbiased Characterization of the Flux Cone:
pathway analysis
Any attempt to enumerate all the possible flux steady-state distributions
lies within the realm of the intangible for typical GSMMs with large num-
bers of reactions and metabolites, since their complexity scales exponen-
tially with the size of the models [97, 98]. This fact is the main driving-force
behind the development of the methods described in the previous section.
Still, within the field of Pathway Analysis, a number of methods have
been put forward towards this purpose, even if currently these are only ap-
plicable to small or medium scale models. The two best known approaches
for the enumeration of the possible flux distributions are Elementary Flux
Modes (EFMs) [99] and Extreme Pathways (ExPas) [98]. Both these meth-
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ods describe minimal (non-decomposable) sub-networks of the system that
operate at steady-state, defining the edges of a convex polyhedral cone (the
flux cone – Figure 2.2). In turn, linear combinations of the vectors repre-
senting these minimal sub-networks yield the totality of the solution-space
(all possible flux distributions).
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1) S.v = 0
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Figure 2.2: The flux cone. In the example, a) - the admissible flux space is defined by the
steady-state and reversibility constraints; b) - an objective function is imposed (subjected
to the previous contraints) defining an optimization problem; and c) - further constraints
are imposed to redirect the flux to a desired region of the flux cone.
EFMs obey the following set of conditions [99]:
1. Steady-state: All elementary modes obey Equation 1;
2. Feasibility: All irreversible reactions proceed in the forward direction,
i.e., EFMs are thermodynamically feasible, obeying Equation 2.2;
3. Non-decomposability: EFMs represent the minimal functional units
in the network; therefore, no reaction can be removed from an EFM
without violating either (2.1), (2.2) or both.
Moreover, these particular conditions yield some important properties:
• (P1): There is a unique set of EFMs for a given metabolic network;
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• (P2): All the feasible steady-state flux distributions satisfying (1)
and (2) are a non-negative superimposition of the set of EFMs in the
network;
• (P3): When a reaction is removed from the network, the set of EFMs
for the new network is equal to the one from the original network, but
removing all the EFMs that include the removed reaction.
These properties render these approaches extremely interesting for meta-
bolic engineering purposes (among others), since they describe the complete
portfolio of steady-state phenotypes, and are conveniently presented as min-
imal metabolic functions.
While both methods are conceptually close to each other, the fact that
ExPas resort to the decoupling of reversible reactions, into equivalent for-
ward and backward reactions, translates into a non-complete overlap of
their corresponding enumerations in many cases. In fact, ExPas are a sub-
set of EFMs, except when the network is solely composed by irreversible
reactions, in which case the two sets should completely overlap.
Given that the previously mentioned enumerations, for genome-scale
or even medium-sized metabolic networks, are computationally unattain-
able, alternative methods based on random sampling of the flux space,
such as Monte Carlo Markov Chain (MCMC) [100] or an adapted canonical
basis approach [101], have been developed to circumvent this limitation.
Moreover, alternative methods focused on achieving particular biological
functions or searching a subset of the flux space [102, 103], are also knowl-
edgeable ways of exploiting this class of methods.
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2.3 Computational Strain Optimization
Methods
Before a formal classification for computational strain optimization methods
(CSOMs) is presented, our vision of what a CSOM is must be clarified.
Computer-aided strain design efforts cover a broad range of applications
and techniques, which leads some authors to mix together optimization
approaches with others that can be considered as phenotype prediction
methods or even strain design algorithms that do not explicitly use any type
of optimization algorithm. To clarify our approach to the classification of
these methods, and as a justification for the inclusion or absence of some
well-known (and, nonetheless, very useful) approaches in this section, some
rules have been drafted for whether or not to consider a method as a CSOM:
1. A CSOM must (try to) provide an answer to a specific top-level ques-
tion, such as: “Which set of perturbations applied to the model (or-
ganism) favors a desired engineering goal?”
2. The exhaustive enumeration of all possible solutions (designs), albeit
highly desirable, is not considered a CSOM since it is considered a
trivial approach (although usually not attainable). Rather, an op-
timization algorithm that defines a strategy to sample the solution
space must be defined to warrant the inclusion of the method in the
review that follows.
3. The algorithms covered in this review are solely the ones based in
constraint-based approaches, following the framework highlighted in
the previous section. We will not cover here other approaches, for
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instance those based in graphs or hypergraphs and their underlying
algorithms, nor any approach based in the use of dynamic models.
2.3.1 Computational Strain Optimization Tasks
CSOMs can be thought of as procedures, which try to answer a practical
question (or set of questions) relevant for strain design. These questions can
be translated into mathematical formalisms and addressed by distinct opti-
mization methods. Powered by phenotype prediction methods and guided
by GSMMs, these methods automatically or semi-automatically search for
answers to questions such as: “Which genes should be deleted from the
model to couple the production of compound X to growth?” or “which for-
eign pathways must be added as to acquire a desirable functionality in a
given host?”. In fact, this last question was probably the first one to arise
when molecular biologists realized the inner potential of recombinant DNA
technology. The most common tasks undertaken by CSOMs are: gene dele-
tion, gene over/under expression, heterologous insertion and, more recently,
co-factor specificity swapping. Some methods also attempt combinations of
these tasks to find better phenotypes.
2.3.1.1 Gene deletion
The suppression of a given metabolic function can be accomplished in vivo
by disrupting the function of specific genes resorting to targeted modifica-
tions through homologous recombination [104] or intron introduction [105].
In silico CSOMs that account for gene deletion (Figure 2.3,a) usually search
for combinations of metabolic function suppressions yielding desirable phe-
notypes. This task is commonly accomplished by imposing constraints that
force the flux of the disabled reactions to zero, deterring the occurrence of
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flux over those reactions, followed by the evaluation of the effect of that
perturbation.
Some recent methods take advantage of the GPR information contained
in the model, and search for combinations of gene deletions (instead of
searching for reaction suppressions), which closer represent the in vivo sce-
nario, since they inherently account for the occurrence of multifunctional
and multimeric proteins, as well as isoenzymes [29].
2.3.1.2 Heterologous insertion
Analogously, the inclusion of non-native functionalities, via gene or pathway
addition, might broaden the metabolic capabilities of desirable hosts, either
by boosting the yields of native compounds or by allowing the production
of entirely new ones (Figure 2.3,b). Typically, algorithms with this kind of
capability, will sort through databases of balanced reactions for the desired
functionality, and try to reconcile them with the original network. The
augmented network can, afterwards, be engineered by other CSOMs to
redirect the flux into the desired direction. Most algorithms specialized
only in the first task, that is, the sorting of heterologous enzymes and
subsequent reconciliation with a target host, are not considered in this
work since they are typically not constraint-based approaches. Examples of
aforesaid methods include DESHARKY [106], BioPathwayPredictor [107]
or FindPath [108].
2.3.1.3 Gene over/under expression
Alternatively, the up/down regulation of gene expression have gained con-
siderable importance in the ME community [109, 110]. Gene over/un-
der expression concerns the fine-tuning of enzyme levels and correspond-
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ing flux rates, which can be accomplished by resorting to promoter li-
braries [111–113] or synthetic biology tools [114]. This approach can be
useful in situations where a gene deletion is lethal whereas a downregula-
tion is not, as well as a solution to overcome flux bottlenecks in certain
steps towards a desired biological function (Figure 2.3,c). These tasks are
usually undertaken through the addition of extra constraints on the reac-
tion fluxes rates, forcing them to operate closer to their maximal or minimal
theoretical bounds.
2.3.1.4 Modulation of cofactor binding specificity
A distinct approach is to tackle the scarcity of some cofactors required
for essential steps of some ME efforts, by modulating the cofactor binding
specificities. A typical example is the modulation of NAD(H) or NADP(H)
availability, due to their importance in the anabolic and catabolic pro-
cesses. By playing with the co-factor binding specificities, it is possible to
establish driving forces in target pathways that require, for example, the
regeneration of one particular cofactor [115]. In vivo modulation of co-
factor specificities has been reported via protein engineering [116, 117] or
by replacing native enzymes with heterologous ones with different cofactor
specificity [118]. This approach can be computationally simulated by swap-
ping the cofactor specificity of some reactions in the network, followed by
a phenotype prediction method to evaluate the effects of the perturbations
(Figure 2.3,d).
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Figure 2.3: Computational strain optimization tasks. In the example, a) - 3 gene dele-
tions force the flux through reactions producing the desired compounds; b) - the inclusion
of two heterologous genes allow the production of an intermediary compound and sub-
sequent excretion of the desired product; c) - the overexpression of two enzymes allow
the excess formation of compound B which is subsequently excreted; and d) - the enzyme
catalyzing the transport reaction R3 is swapped by an heterologous enzyme using NADH.
The deletion of a membrane oxidoreductase enzyme creates an excess of NADH that can
be used by the new transport reaction to excrete compound F.
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2.3.2 A Taxonomy for Computational Strain
Optimization Methods.
The set of CSOMs reviewed in this work has been organized and classified
under several aspects, including the strain design task(s) addressed, the op-
timization algorithm, mathematical formulation, the method’s scalability,
the validation case studies and the availability of the method in a software
implementation. This information is provided in Supplementary Table 1,
being the methods sorted chronologically.
A classification (or “taxonomy”) for CSOMs is proposed in this work
based on the features of each method. An obvious classification would be
to group them based on the task they try to accomplish, as explained in
the previous section. While keeping this also in mind, we prefer to analyze
them primarily based on their optimization frameworks and mathematical
formulations. Following this principle, three main branches emerged in
our analysis: bilevel mixed-integer programming (MIP), metaheuristics and
elementary modes analysis (EMA) based methods.
2.3.2.1 Bilevel Mixed Integer Programing methods
In 2003, Costas Maranas’ group reported a specialized method to pursuit
productive gene deletion strain designs coupled to cellular growth. This
method, OptKnock [18], detailed a bilevel framework, where two competing
objective functions were simultaneously accounted for. The inner problem
concerned the biological objective of the organism, in this case maximiza-
tion of cellular growth, while the outer problem focused on the engineering
goal, the overproduction of a desired compound. The method suggested re-
action deletions, which were imposed as constraints for the inner problem.
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This elegantly formulated mathematical framework profited from the strong
duality property, which stated that if the primal and the dual optimal so-
lutions are bounded, then at optimality, the gap between both objective
function values must be zero [119]. This property allows the bilevel formu-
lation of OptKnock to be transformed into a single-level MILP, by setting
the primal and dual objectives equal to one another and accumulating their
respective constraints. OptKnock represented a breakthrough in the field,
establishing the framework used by many of the developed CSOMs until
present days. Figure 2.4 summarizes the main properties of the bilevel for-
mulation and its conversion to a single-level MILP, introduced by OptKnock
and which establishes this category of CSOMs’ distinct characteristics.
One of the strong properties of OptKnock solutions is that they are
mathematically guaranteed to be optimal, given the defined task and ob-
jective function. However, they can often be considered as overly optimistic
in real world scenarios. The fact that the target production is coupled to
the biomass formation, results in OptKnock selecting the “best” solution,
the one with highest product yield given a pre-defined minimum biomass
flux value and a maximum number of reaction deletions, but is not able to
account for competing pathways that might redirect the flux, lowering or
even zeroing the expected product yield.
To address this issue, Tepper and Shlomi suggested the RobustKnock
[120] method, a reformulation of the OptKnock procedure that optimizes
the worst-case scenario for the product formation coupled to cellular growth,
that is, a guaranteed (robust) lower bound for the expected growth coupled
product formation. The max-min formulation of RobustKnock yields a
triple-level problem, an outer max-min problem that searches for a set of
knockouts maximizing the minimal production rate of the target compound
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Figure 2.4: Simplified example of the coupling strategy introduced by OptKnock, allowing
the transformation of a bi-level MILP into a single-level one. The top region depicts
the bi-level MILP problem (left) and the dual of the inner problem (right). For each
constraint in the primal, there are one or more dual equivalents. Using strong duality
theory and accumulation of constraints, the single-level MILP formulation is attained
(bottom).
(a bilevel problem), and an inner problem similar to that of OptKnock,
searching for a feasible flux distribution maximizing biomass. The outer
problem is transformed into a standard max-min problem using a procedure
similar to that used in OptKnock and, subsequently, transforming it into a
standard MILP problem.
Shortly after, Feist and co-workers, as an alternative approach to ad-
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dress the robustness issues brought up by OptKnock, introduced objective
function tilting [121]. Albeit not being a CSOM by itself, objective func-
tion tilting represents a valid, computationally lighter, alternative to Ro-
bustKnock, since it only involved small changes in the objective function
of OptKnock (and also of OptGene, referred in the next section), without
increasing its computational complexity. In OptKnock, this approach in-
volved subtracting the target product multiplied by a very small weight
to the inner problem’s objective function. This forced the algorithm to
identify the solution with the highest minimum production rate, among the
ones with optimal value for the inner problem.
More recently, Kim and co-workers introduced BiMOMA as an alterna-
tive to OptKnock [122]. BiMOMA is a new bilevel CSOM for the design
of gene deletion strategies. It is formulated as a mixed-integer quadratic
constrained programming problem (MIQCP), which uses MOMA as the in-
ner phenotype evaluation method (opposed to OptKnock’s FBA). In their
work, several techniques to reduce the scalability problems traditionally
associated with MIP formulations were also suggested. These techniques
include the tightening of the bounds of the dual variables using a sampling
technique, the application of penalties for genetic perturbations (favoring
smaller designs), reduction of the search space, and finally the use of it-
erative methods as a way to improve the performance of the solvers. The
applicability of BiMOMA was demonstrated for the production of gluta-
mate and pyruvate in E. coli.
A similar approach was suggested by Ren and co-workers [123] with
MOMAKnock. The adoption of MOMA as the inner problem once again
yielded a mixed integer bilevel quadratic programming (MIBQP) formula-
tion but, contrarily to BiMOMA, it was not converted to a MIQCP. Due
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to the heavy computational burden caused by the MIQCP formulation, the
authors proposed the use of an adaptive piecewise linearized inner problem
to approximate the quadratic objective function of MOMA. The proposed
formulation was benchmarked against OptKnock results, in the search for
succinate productive E. coli strain designs.
Very recently, researchers from the Chinese Academy of Sciences ques-
tioned the validity of the duality theory transformation employed by most
of the previously described CSOMs [124]. They argue that, by not including
the lower level primal variables in the dual objective, the single level MILP
problem in which OptKnock relies was erroneous derived. More explicitly,
they argue that if the problem had been correctly formulated, a mixed in-
teger nonlinear programming problem (MINLP) would emerge instead of
a MILP. Subsequently, they suggest a method based on the Karush-Kuhn-
Tucker (KKT) [125] technique to reformulate the Mixed Integer Bilevel
Linear Problems (MIBLP) problem as a single level MILP (applicable only
when the inner problem is continuous), and propose ReacKnock as a more
reliable alternative to OptKnock. However, more recently Chowdhury and
coworkers released a new work [126] where the peculiarities of the OptKnock
formulation are more thoroughly explained. In particular they elaborated
on the application of the complementary slackness conditions to justify the
absence of some of the lower level primal variables in the dual objective
function thus restating the formulation of OptKnock as completely valid.
The optimization of reaction deletions was not the only task addressed
by this class of methods. Shortly after the publication of OptKnock, Maranas
and co-workers extended the developed framework to support enhancing a
desired host with non-native functionalities via heterologous enzyme addi-
tions. This method was termed OptStrain [127] and was implemented as a
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multi-step approach. Profiting from the myriad of biological data sources
available, such as KEGG [128, 129], MetaCyc [130] or BRENDA [131], the
authors created a universal reaction database which OptStrain uses as a core
for finding the reactions that can be added to the host GSMM. With this
knowledge base in place, the OptStrain procedure computes the maximum
theoretical product yields for a given substrate, considering both native
(from the GSMM) and non-native reactions (from the database). After-
wards, the minimal number of non-native functionalities yielding balanced
pathways are sought and included in the original stoichiometric model. Fi-
nally, the OptKnock framework is employed to find additional knockouts
that further increase the yields. The OptStrain framework was used to
identify metabolic engineering strategies for the production of hydrogen
and vanillin in C. acetobutylicum and E. coli, respectively.
In 2011, Kim and co-workers revisited and improved the OptStrain
framework, by considering both gene deletions and heterologous insertions
simultaneously [122]. This method, SimOptStrain, is aware of GPR re-
lationships, which potentially allows for more biologically feasible designs
since the target here is to find good combinations of genes to knockout.
The new method was demonstrated in the design of succinate and glycerol
productive strains of Escherichia coli.
Yet, the portfolio of possible genetic manipulations was not complete
with the development of OptKnock, OptStrain and related methods. As
previously stated, the tuning of gene expression and related enzyme levels
is another important task in strain optimization. The OptReg [132] frame-
work was the first CSOM to allow searching for optimal gene expression
levels, together with gene-deletions as provided by OptKnock. To this end,
additional binary variables referring to the up and down regulations and
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knockouts were considered:
ydj =
0, if reaction j is downregulated,1, otherwise
yuj =
0, if reaction j is upregulated,1, otherwise
These act as switches that restrict the flux in response to the respective
perturbation (over/under expression) based on the following supplementary
constraints:
vminj ≤ vj ≤ [v0j,L.(1− C) + vminj .C].(1− ydi ) + vmaxj .ydj ,∀j ∈ N
for downregulations, and:
[v0j,U .(1− C) + vmaxj .C].(1− yuj ) + vminj .yuj ≤ vj ≤ vmaxj ,∀j ∈ N
for upregulations, were, vminj and v
max
j are the lower and upper limits of
flux j defined in the GSMM, v0j,U and v
0
j,L the lower and upper limits of flux
j determined by flux variability analysis (FVA) [133] and C is the regula-
tion strength parameter considered in the interval [0, 1]. Higher values of C
correspond to stronger regulations. Furthermore, constraints stating that
a reaction can only be subjected to one manipulation (knockout, down-
regulation or upregulation), constraints limiting the maximum number of
manipulations allowed and constraints forcing the mutual knockout of the
two directions of reversible reactions are also taken into account. OptReg
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was illustrated with the determination of engineering strategies for the pro-
duction of ethanol in E. coli.
Almost concurrently, Ranganathan and colleagues published an alter-
native method named OptForce [134], which was supported on a different
but rather insightful concept. The workflow is initiated by a characteriza-
tion of the wild-type strain, resorting to FVA to determine the lower and
upper bounds of each flux (this task can be aided by experimental data if
available). By iteratively considering sets of reactions (pairs, triples, etc),
OptForce generates a set of reactions that are required to change to achieve
a user defined production yield (termed the MUST set). From this set, a
new step proceeds to characterize the minimal set of reactions that need
to be forced via genetic manipulation (termed the FORCE set). The proof
of concept was performed in the production of succinate in E. coli. Poste-
rior experimental validation led to interesting results for other targets in E.
coli [135, 136] (further details in the next section).
A similar approach was recently proposed by Cotten and Reed [137],
termed CosMos, that incorporates flux up/downregulations in a more flex-
ible manner than OptForce since changes to bounds can be chosen contin-
uously. Their results report additional solutions compared to OptForce, in
a case study for succinate production with E. coli.
With the scalability problems of traditional MIP formulations in mind
[121], Mahadevan and co-workers proposed the EMILIO (enhancing metabolism
with iterative linear optimization) approach [138]. The foundational frame-
work employed by EMILIO is very similar to that of OptReg, with the
exception that the inner problem’s objective function enforces the maxi-
mization of a minimal production rate, thus addressing the concerns first
raised by Shlomi et al [120]. The bi-level problem is reformulated into a non-
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convex single-level mathematical program with complementary constraints
(MPCC), which is solved using a three-step approach. First, an iterative
linear programming (ILP) is applied to establish the set of active constraints
(flux bounds), followed by a recursive LP-based pruning method that iden-
tifies subsets of active constraints required to achieve a user-specified frac-
tion of the maximum production rate. In the final step, for each subset,
a MILP procedure similar to OptReg is employed to minimize the number
of reaction modifications required to satisfy the user-specified fraction of
the maximum production rate. EMILIO was demonstrated in the design of
various deletion/ over/under expression E. coli mutants for the production
of succinate, L-glutamate and L-serine.
A distinct method is OptORF, released in 2010 by Kim and Reed [139]
that was the first to address strain optimization using metabolic-regulatory
integrated models. Similarly to previous approaches, OptORF was for-
mulated as a bi-level MILP problem, capable of suggesting metabolic en-
gineering growth-coupled production designs. Uniquely though, OptORF
designs consisted on both metabolic and regulatory gene deletions as well
as metabolic gene overexpressions. These make use of Boolean rules defin-
ing the relations between reaction and metabolic genes (GPRs), as well as
rules that define transcriptional regulation. Both are transformed into lin-
ear constraints. The applicability of this method was, however, limited by
the scarcity of available integrated metabolic/regulatory models to profit
from all its features. OptORF has been applied in the design of ethanol,
isobutanol and 2-phenylethanol E. coli producing strains.
Complementary to the various described approaches for gene deletion,
gene over/under expression and heterologous insertion, some alternative
CSOMs with unique characteristics have also been proposed.
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An exquisite new method, OptSwap, was very recently proposed by
King and Feist [115]. OptSwap was the first and, until today, the only
method to consider the cofactor binding specificity of enzymes as possible
targets for computational strain optimization. More specifically, OptSwap
focuses on oxidoreductase enzymes and their binding specificity for either
NAD(H) or NADP(H). However, the authors state that the principles and
framework are extensible to other specific sets of interest. A pool of swap
candidate oxiydoreductase enzymes is selected beforehand, based on litera-
ture and in silico limitations. The problem is formulated as a MILP similar
to RobustKnock, but including additional constraints to enforce swaps of
the cofactor specificities of the previously selected reactions. This is ac-
complished by extending the model with a set of reactions with opposite
cofactor specificity to the ones in the pool. Extra constraints are added to
force the knockout of either the native or the swapped reaction and to limit
the number of both swaps and deletions. The OptSwap procedure was used
to identify non-intuitive designs for several end products in E. coli, some of
which were not possible by gene deletions alone.
The most recent effort in MIP-based CSOMs combines the kinetic de-
scriptions of metabolic steps with traditional stoichiometric models, to im-
prove their predictive power and suggest more accurate designs [140]. By
bridging the gap between stoichiometric and kinetic-based models [141], k-
OptForce may represent a game changer and a new chassis for future CSOM
development efforts. Alternatively to most CSOMs, k-OptForce does not
rely on assumptions such as the maximization of biomass or minimization
of metabolic adjustments as a fitness function, but rather makes use of
available kinetic rate laws to predict flux distributions. To meet this end,
the reactions in the metabolic network are split into two sets, one contain-
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ing reactions for which kinetic information is available (Nkin), and another
for the reactions with only stoichiometric information (N stoic). While the
reactions in N stoic are constrained by mass-balances and thermodynamics,
the ones in Nkin are subjected to the enzyme kinetics, metabolite concen-
trations and kinetic parameter values. Consequently, the Nkin part of the
network is represented as a system of nonlinear ordinary differential equa-
tions (ODEs).
The k-OptForce procedure is subsequently solved in two steps: first, a
characterization of the wild-type is done, by solving the system of ODEs to
obtain a steady-state flux distribution for Nkin, and by using FVA for the
N stoic reactions. Similarly, the characterization of the overproducing strain
is performed subject to the kinetic and concentrations constraints, where
available. Finally, the computation of MUST and FORCE sets (81) is re-
formulated to account for the newly introduced kinetic layer. The introduc-
tion of nonlinear kinetics into the formulation translates into a single-level
mixed-integer nonlinear optimization problem (MINLP), which needs to be
addressed resorting to NLP solvers. The k-OptForce formulation was con-
trasted with the original OptForce, for the prediction of L-serine and Tal
mutants, in E. coli and S. cerevisiae respectively.
Overall, the class of methods described in this section presents numerous
advantages and has led to several successful applications that will be covered
later. Yet, albeit the formulation of strain optimization problems on top of
the OptKnock framework yields exact solutions for the defined formulations,
the methods have problems with the underlying computational complexity.
This constrains, for instance, OptKnock and related methods to a relatively
low maximum number of allowed transformations, as the consideration of
higher numbers would make the methods hard to apply in current GSMMs.
Paulo Maia University of Minho, 2015
The Quest for Optimal Cell Factories| 43
Also, the use of a MIP framework restricts these methods to the use of linear
objective functions that do not necessarily express the complexity of the
bioengineering objectives. Lastly, these methods rely on a tight coupling of
the two levels, the phenotype simulation and the strain optimization layers,
which also reduces their flexibility. This is clearly illustrated by the fact
that there is a need to define a new method when an optimization approach
developed for a specific simulation method is to be applied to another one,
such as changing from FBA to MOMA.
2.3.2.2 Metaheuristic CSOMs
The problems associated with the previous methods stated above motivated
the development of a separate class of approaches, supported on a more
heuristic rationale. Heuristic methods are usually computationally less ex-
pensive approaches for a myriad of optimization problems. Although, due
to their nature, they do not guarantee that the overall optimal solutions
are found, they allow the definition of optimization frameworks with an en-
riched set of objective functions and that foster a more clearer separation of
the strain optimization from the phenotype simulation methods. In Figure
2.5, a generic workflow for a typical metaheuristic CSOM is presented.
The first effort to move in this direction was OptGene [142] presented
by Patil and co-workers, that appeared shortly after the publication of Opt-
Knock and OptStrain. Inspired by the Darwinian natural evolution theory,
OptGene formulates a bi-level decoupled approach, supported by the use of
a genetic algorithm [143]. The idea is to encode solutions as individuals in
an evolving population. Here, each solution is represented as a set of inte-
ger values encoding reaction deletions. The algorithm starts by the random
generation of an initial set of candidate solutions (the initial population),
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Figure 2.5: Workflow of generic metaheurist CSOM. The separation of the several layers
(model/phenotype prediction/strain optimization) is easily visible.
each is decoded into a set of reaction deletions, which are translated into
constraints and flux distributions are predicted using FBA. A fitness value
is assigned to each solution by a user-defined objective function such as the
Biomass-Product Coupled Yield (BPCY), which is an example of a non-
linear objective function that resembles productivity. Subsequently, the
algorithm enters an iterative stage, starting with a selection step, which
chooses solutions as primary candidates for reproduction, in a stochastic
way that depend on their previously assigned fitness (fitter individuals have
more probability of generating offspring solutions). Finally, by combining
these individuals via crossover or mutation operators, a new population is
attained and re-evaluated. This cycle is repeated until a desired phenotype
is achieved or another user-defined termination criterion is met.
Although these methods, as the previous ones, still follow a bi-level de-
sign, in this case the bioengineering and the biological optimization tasks
are clearly decoupled and are performed independently. This decoupling of
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the outer and inner optimization problems translated into some very pow-
erful properties: first, complex designs involving a larger number of pertur-
bations can be tested without affecting the computational tractability of
the problem. Secondly, the decoupling of the outer and inner optimization
problems allows for a more flexible tuning of both layers, for example, the
inner phenotype evaluation method can easily be swapped amongst FBA,
MOMA, ROOM, or any other phenotype simulation method, for instance
including the ones using regulatory constraints (such as rFBA or SR-FBA).
Another important advantage is the flexibility in the definition of the
objective function in the outer problem, which is here not bounded by
linearity. Non-linear objective functions (even discontinuous) can easily be
included, as is the case with the BPCY, allowing to define more meaningful
and powerful functions. The flexibility gained by the decoupling of the two
layers also allows the easier switch of the optimization heuristic used to
search for metabolic engineering strategies and also to address the different
optimization tasks with a similar framework.
In the original publication, the OptGene method was first used to sug-
gest S. cerevisiae designs for the production of vanillin, glycerol and suc-
cinate. Since then, taking advantage of the flexibility provided by this ap-
proach, the framework has been thoroughly extended to support additional
features and algorithms. Rocha and co-workers provided a reformulation of
OptGene where set-based evolutionary algorithms (SEA) and simulated an-
nealing (SA) algorithms were used in the outer optimization problem [144],
enabling a more compact representation and the simultaneous optimiza-
tion of the number of knockouts. Also, extensions were proposed where
metabolic engineering strategies consider both metabolic and regulatory
genes as targets [145] and gene over/under expression [146].
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A very similar method, Cipher of evolutionary design (CiED) [147], was
also developed and experimentally validated in E. coli for the increased
production of malonyl-CoA. More recently, Constanza and Nicosia revis-
ited the robustness issues of suggested genetic interventions [148]. The
proposed genetic design through multi-objective optimization (GDMO) is
inspired in the non-dominated sorting genetic algorithm II (NSGA-II) [149],
a multi-objective evolutionary algorithm (MOEA) which uses the Pareto
optimality principle to find the optimal (or near optimal) trade-off solu-
tions in a multi-objective optimization problem. The procedure begins by
the pre-processing stage, where a sensitivity analysis on the model ranks
the various pathways according to their influence on the outputs. Subse-
quently, the MOEA searches for both gene deletions and nutrients, specified
by the objective functions. Finally, a robustness analysis task selects the
most locally and globally robust designs as ideal candidates for implementa-
tion. This procedure was applied in E. coli for the production of succinate
and acetate, and its results were compared with those of GLDS, OptGene,
SEAs/SAs and OptKnock.
The genetic design through local search (GDLS) method [150] embraced
the problem from a different perspective. By using iterative local search
steps, building on previous solutions, GDLS is capable of suggesting efficient
strain designs, involving a larger number of genetic interventions (both gene
deletions and over/under expressions). However, as later pointed out [138],
the complexity still increased exponentially with larger scopes of each local
search. GLDS proof of concept was established by suggesting acetate and
succinate E. coli productive strains.
Later, part of the GDLS team also participated in the development
of the genetic design through branch and bound (GDBB) [151] approach.
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GDBB uses a truncated branch and bound technique to tackle the scal-
ability problems associated with the bilevel MILP problem introduced by
OptKnock. The formulation, similar to that of OptKnock, makes use of
the Gurobi solver (Gurobi Optimization, Houston, TX, USA) particular
implementation of the truncated branch and bound algorithm, and exploits
its optimality and feasibility configuration options to fine-tune the trunca-
tion process. By not allowing the solver to reach optimality, but rather
forcing it to stop at near-optimal solutions (considered sufficient for practi-
cal purposes), the performance of the method improved significantly when
compared to previous approaches. Such technique is readily applicable to
any method whose foundational framework is a bilevel MIP, for which a
single-level MIP equivalent is attainable.
More recently, Rockwell and co-workers presented the Redirector ap-
proach [152]. The Redirector method is based on the iterative local search
technique used by GDLS, but introducing a novel objective function recon-
struction cycle in the iterative procedure. This novel cycle is composed of
two steps: the first one, called “objective control”, finds metabolic engi-
neering targets and adds them to the objective function while the second
one, designated “progressive target discovery”, iteratively adjusts the con-
tribution of growth to the objective function, redirecting resources to the
optimization of the target compound. Important in this method is the idea
to simulate over/ underexpression of enzymes, by including the fluxes in
the objective function with positive and negative coefficients, respectively.
This approach was applied to the discovery of novel E. coli designs for the
production of fatty acids.
The latest noteworthy heuristic CSOM presented is FastPros [153], an
efficient screening procedure based on shadow prices analysis. This algo-
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rithm introduces a novel score for knockout screening (µtarget), which corre-
sponds to the shadow price of the sink flux associated with the compound of
interest (for an FBA problem maximizing biomass production rate). This
new score represents the potential for target production, and is calculated
by the following relationship:
µ =
δvgrowth
δvtarget
where δvgrowth is the variation in the biomass production caused by an
increase of δvtarget from zero flux. A positive value of µtarget represents
growth-coupled production of the target compound. The procedure begins
with the computation of every double knockout strategy and corresponding
µtarget values, from which a set of P parent sets are selected with regard to
that score. At this point, the iterative procedure begins, consisting in the
generation of knockout sets by adding every possible single knockout to ev-
ery parent set in P (yielding P×N sets), recalculating the δvtarget values and
re-initializing the procedure with the new set of P parents. However, the
value of δvtarget is only related with the benefit towards growth, rendering
the iterative procedure insufficient for the purpose of finding high productiv-
ity strain designs. For this purpose, the authors proposed a modification in
the OptKnock procedure, where the candidates for reaction knockouts are
limited to those selected by FastPros, which yielded very positive results.
The FastPros procedure was used in the screening of geranyl diphosphate
and L-phenylalanine E. coli designs.
2.3.2.3 Elementary modes analysis based methods
The final group of methods includes the CSOMs that use elementary modes
analysis (EMA) as their foundational framework. Klamt and Gilles intro-
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duced the concept of minimal cut sets (MCSs) in 2004 [154] representing the
first draft of what an EMA-based framework for strain optimization could
look like. A minimal cut set describes an irreducible group of reactions
required to disrupt a determined network function (a targeted reaction -
robj), and thus, in a certain way, MCSs are the opposite of EFMs, which
describe the minimal functional modes. Similarly to EFMs, the set of MCSs
in a network is also unique. As a limitation, the computation of the EFMs
of the network is required a priori, which has limited the uses of MCSs
to small to medium size networks. After the computation of the EFMs
is performed, the EFMs set is divided in two sub-sets, one containing all
the EFMs that involve the target reaction robj (the target modes - E
t) and
another containing all the EFMs that do not involve the target reaction
(the non-target modes - Ent). By ensuring that all the target modes be-
come inactive after the removal of a set C of reactions, then only non-target
modes will be left hence, by the definition of EFMs, it is no longer possible
to find a feasible flux distribution involving robj. An MCS “hitting” all
target modes is termed a minimal hitting set and the computation of the
minimal hitting sets from the set of target modes can be performed using
the Berge algorithm [155]. In this work, several MCSs possible applications
have been discussed, including: target identification and repression of cel-
lular functions, network verification and mutant phenotype predictions, as
well as structural fragility and robustness analyses. Later, the concept of
MCSs was refined, generalized to multiple targets and its duality properties
with EFMs were studied in more detail [156].
The main limitation of the MCS approach is that, by being focused on a
target functionality to be disrupted, it is rendered oblivious to possible side
effects over other desired functionalities. To tackle this limitation, Ha¨dicke
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and Klamt developed a generalized approach of MCSs termed constrained
minimal cut sets (cMCSs), allowing for the inclusion of side constraints
[157]. A cMCS C is now admissible if it hits all target modes, but also
maintains a minimum number n of desired EFMs. It is not expected that
this set (D) will keep all the desired modes, meaning that it is possible
that some of the desired modes will also be hit by some MCSs. However,
the set of desired modes not hit by any MCS (DC) is bounded by |DC | ≥
n. The introduction of these constraints implicated an adaptation of the
Berge algorithm. This approach has been demonstrated for the production
of ethanol in E. coli. The inclusion of regulatory constraints into cMCSs
was later done by Jungreuthmaye and Zanghellini, devising the regulatory
constrained MCSs (rcMCSs) [158].
Concurrently, Srienc and collaborators presented another EMA-based
approach named minimal metabolic functionality (MMF) [159]. This ap-
proach iteratively searches for all the combinations of gene deletions that
will eliminate all undesired EFMs, while keeping a set of optimal or near
optimal ones intact. Similarly to other approaches, coupling of biomass and
product synthesis can be enforced by the selected knockout strategies. The
application of MMF yields a network containing only its most efficient path-
ways, and its applicability was verified experimentally for the production
of several secondary metabolites in E. coli.
The first EMA-based approach to consider other types of metabolic
engineering interventions besides knockouts was FluxDesign [160]. This
procedure first computes the set of EFMs resorting to the EFMTool [161],
followed by a normalization step, that for a given EFM calculates the rel-
ative flux for each of its reactions, normalized to the substrate uptake.
Finally, to decide whether or not a given reaction r represents a potential
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intervention target, a chosen set of EFMs is searched for (statistically) sig-
nificant correlations between the flux through the objective reaction and the
flux through reaction r. This strategy yields targets for both amplification
(up regulation) and attenuation (down regulation). FluxDesign was demon-
strated for lysine and enzyme production in C. glutamicum and Aspergillus
niger, respectively.
Another approach for suggesting multiple types of genetic interventions
came from Ha¨dicke and Klamt [162]. The proposed computational approach
for strain optimization aimed at high productivity (CASOP) is based on re-
action importance measures, where their relative contributions to yield and
flux capacity are taken into account. With the purpose of finding growth-
coupled high-productivity strain designs for a target product P, the pro-
cedure begins by considering an artificial external metabolite (V),which is
produced from biomass and the target product by a reaction (here simpli-
fied):
Rv : (1− γ)BM + γP (ext)→ V, γ ∈ [0, 1]
with γ representing the relative production of P (ext) with respect to
biomass (BM) synthesis. By iteratively increasing the parameter γ, com-
puting the set of EFMs for the new scenario, and recalculating the EM
weights and reaction importances, the procedure yields a set of candidates
for knockouts and overexpressions. Succinate over-productive strain designs
were suggested in E. coli to demonstrate the applicability of this approach.
More recently, Trinh and co-workers presented the systematic multiple
enzyme targeting approach (SMET) [163]. This method uses cMCS to
find the set of modes maximizing a desired product yield, and ensemble
metabolic modeling (EMM) to generate ensemble models representing the
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steady-state phenotype of the wild-type strain. Afterwards, SMET is used
to systematically identify sets of enzyme targets to engineer the wild-type
strain to reach the desirable phenotype. The SMET approach is capable
of suggesting designs based on deletions or over/under expressions and has
been validated in the DHAP metabolic network. Until recently, the use
of EMA-based methods, including application to strain optimization, was
limited to small to medium scale metabolic networks, as the number of
possible EFMs increases exponentially with the network size. Indeed, all
previously mentioned validation examples do not use GSMMs, but rather
small/ medium sized models with selected pathways.
Some approaches to circumvent this issue have been suggested in the
past [164, 165], but with limited applicability in this context. A big step
forward into bringing EMA-based CSOMs to the genomic scale, was taken
by de Figueiredo and collaborators, with the publication of a method to
generate the shortest EFMs in a genome-scale metabolic network [166].
While not being able to find all EFMs for the network, this method allows to
calculate iteratively sets of EFMs of interest for a given ME task (e.g. those
achieving a given, or set of, chemical transformations). As an illustration,
the method has been employed within CASOP to extend it to genome-scale
metabolic models via an heurist approach named CASOP-GS [167].
Even more noteworthy is the latest work of Kamp and Klamt, MC-
SEnumerator, published in early 2014. By exploiting the dual properties
of EFMs and MCSs and combining them with a modified version of the de
Figueiredo approach, MCSEnumerator is able to identify thousands of the
most efficient intervention strategies in a genome-scale metabolic network,
involving up to 7 knockouts. More specifically, they begin by converting
the original network and intervention objective to its dual form, following
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the Ballerstein approach [168] followed by an enumeration of the k shortest
EFMs in the dual network using the modified version of the de Figueiredo
approach. The EFMs in the dual network correspond to the MCSs in the
primal, thus, the shortest EFMs in the dual will correspond to the smallest
MCSs in the primal. The framework is formulated as a MILP problem, ele-
gantly extended to represent sets. Afterwards, MCSEnumerator is demon-
strated, first by enumerating all the synthetic lethals up to 5 knockouts in
a GSMM of E. coli [41], followed by the enumeration of all the cMCSs up
to 7 reactions leading to growth-coupled ethanol production in the same
model.
2.3.3 Comparative Analysis of the different classes
of CSOMs
After reviewing all the relevant methods, it is important to provide an
overall discussion of their merits and limitations. Figure 2.6 supports this
discussion by organizing the most relevant methods according to several
criteria, including scalability, ability to generate exact optimal solutions
and year of development. Also, other aspects related to the optimization
task, experimental validation and patent applications are also represented.
Importantly, in the figure, the links represent an attempt to define the
methods’ phylogeny, i.e. to identify methods that are extensions or, at
least, are strongly based in previous ones.
One important trend that is clear from Figure 2.6, looking at the dates of
development, is the growing number of published methods over the last few
years. This ascertains the relevance of the problem and the growing need
for efficient strain optimization methods. Another observable conclusion
is the clear trade-off between scalability and the guarantee to reach the
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Figure 2.6: Properties of CSOMs and their relationships. The target plot is sectioned into
4 discrete quadrants regarding scalability and exactness. Methods in the upper region are
considered more scalable while methods in the bottom region are considered less scalable.
Similarly, the methods located in the right region of the figure guarantee that, if it exists,
the optimal solution for the specified objective function is always found, while the methods
in the left region, being inherently heuristic, do not. Other features are indicated in the
legend (bottom of the figure).
global optimal solution. Most MIP and EMA-based methods’ formulations
guarantee that, for the implemented objective function, the global optimal
solution is always found. To do this, the complexity of the mathematical
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formulations is usually incremented in such a way that, for larger models or
for a higher number of tested perturbations, they usually do not scale well.
Some authors addressed these scalability problems by suggesting ways to
simplify the problems in MIP-based methods [122, 138] or by computing
subsets of the solution space in EMA-based approaches [166]. The recent
developments from Klamt and co-workers [169] hold the promise to scale-
up EMA-based strain optimization and boost their utility in real-world
applications.
Another approach is the use of metaheuristic CSOMs, which usually
scale well with larger models or higher number of tested perturbations.
However, there is no guarantee that the global optimal will be found. When
the solution space is large enough, they will usually reach optimal or near-
optimal solutions faster than MIP or EMA-based methods. However, even
if they often perform better than these methods in large scale problems,
since further increasing the number of allowed perturbations will cause the
solution space to grow exponentially, this might make it hard even for meta-
heuristic methods to find good solutions.
Metaheuristic methods are also more flexible when it comes to the spec-
ification of objective functions since they are not bounded by linearity. For
most MIP-based methods, the introduction of a non-linear objective func-
tion will yield computationally very expensive MINLP problems.
The inclusion of support for gene based intervention strategies, through
GPR information, within the strain design methods is another trend adopted
by several authors along the years. Although this increases the complex-
ity of the overall approach, most solutions reached when only reactions are
accounted for, will be unfeasible once the GPR relationships are scruti-
nized. Common problems in this context are related with the existence of
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isoenzymes and, more importantly, to the fact that the same gene might
be associated with several reactions, some of which can be essential for
biomass growth and others important for redirecting the metabolic flux
when removed.
One important aspect for the applicability of the discussed methods is
how easily they can be accessed and used. Despite descriptive formulations
for most of the methods are provided in their respective publications, their
implementations are generally not available. The methods from the Opt-
Gene family (EAs/SAs) and OptKnock can be readily accessed through
the OptFlux workbench [170] and all the code is available under a GPL
open-source license. The COBRA toolbox [171] also provides open-source
implementations for some of these methods, such as OptKnock, OptGene
and GDLS, however, it depends on the commercial software MATLAB (The
MathWorks Inc., USA). Moreover, access to most of the methods from the
Klamt group, such as CASOP and cMCS, is provided via CellNetAna-
lyzer [172], but the source code is not disclosed. Complete information
regarding the availability of the discussed methods has been included in
the supplementary table 1.
2.4 Applications and Discussion
GSMM reconstructions and related querying methods have been employed
as guiding tools for the development and optimization of bioprocesses for a
wide range of industrially relevant chemicals, such as lycopene [173, 174],
malate and succinate [175, 176], L-threonine [177], L-valine [178] and di-
apolycopendioic acid [179]. Other applications include bio-fuels, such as
bioethanol [180] or biohydrogen [181], and drug target discovery [59, 182].
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Recent reviews discussing the various applications of GSMMs are avail-
able [14, 183–186].
Despite the positive results accomplished by employing GSMMs and
related querying methods, elaborate strategies such as amplification/at-
tenuation of gene expressions or strategies requiring multiple types of in-
terventions, are neither attainable by simple network inspection nor by
exhaustive/iterative strategies [187]. For these complex and non-intuitive
strategies, the use of CSOMs is put forward. Academic researchers have
concentrated some efforts into the validation of such methods. However,
it is still not clear whether the application of CSOMs in guiding ME ap-
plications is already being used by the industry or if it is only limited to
the academic spectrum. Since CSOMs are centerpiece of this review, in the
following discussion we will mainly focus on applications where at least one
of the discussed methods has been employed. To support this discussion we
put together Table 2.2, which provides a summary of the main experimen-
tal validations performed for CSOMs results, and Table 2.3, where some
industrial patents and patent applications referring to the use of at least
one CSOM are listed.
Two years after the publication of OptKnock, Fong and co-workers
implemented the predicted gene deletions for growth-coupled lactate pro-
duction in E. coli and performed the first experimental validation of a
CSOM [188]. They concluded that the constructed strains were not only
overproducing lactate, but that this production was indeed coupled to
growth, according to OptKnock predictions. Notwithstanding this positive
confirmation, some discrepancies between the computationally predicted
and experimentally observed growth rates were also reported. Since then,
OptKnock has been employed in several other efforts, including increas-
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ing the respiratory rate in G. sulfurreducens [189] and the production of
1,4-butanediol [190] and 2,3-butanediol [191] in E. coli and S. cerevisiae
respectively. More recently, particularly through the hands of Genomatica
(Genomatica, Inc. USA), several patent applications referring to the use
of OptKnock have been filled, related with the development of microorgan-
isms for the production of adipic acid [192], 1,4-butanediol [193, 194] and
the polyester precursor cyclohexanedimethanol [195]. Another patent appli-
cation mentioning OptKnock and OptStrain in the engineering of primary
alcohol producing microbes has also been filed [196].
Subsequently, the usefulness of some heuristic CSOMs was also grad-
ually asserted. Asadollahi and co-workers resorted to OptGene to find S.
cerevisiae sesquiterpene-producing mutants with 85% increase in titer [197].
Here, the flexibility of the decoupled bi-level heuristics became evident,
since the authors employed MOMA as the phenotype simulation method.
A year later, Brochado and colleagues revisited S. cerevisiae, this time for
the overproduction of vanillin, resorting to OptGene as the strain design
method, which resulted in a 5-fold increase when compared to a previous
report [200]. Discrepancies between the predicted results and the batch
cultivations were attributed to the lack of kinetic and regulatory informa-
tion, reinforcing the need to invest in the integration of such information
with GSMMs and in the development of simulation and optimization meth-
ods that take this information into account. More recently, Otero and co-
workers employed OptGene in the design of a S. cerevisiae strain, which
improved succinate yield on biomass by 43-fold in comparison with the
reference strain [205]. Moreover, in 2013, Invista (Invista North Amer-
ica S.A.R.L. USA) filed patent applications referring to the use of Opt-
Flux [170], whose implemented strain optimization methods are direct de-
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Table 2.2: Experimental validation of CSOMs found in the current literature.
Organism
(model)
Application Year Methods Results Ref
E. coli
(iJR904)
Lactate 2005 OptKnock
- 25% increase in pta-adhE strains;
[188]
- 73% increase in pta-pfk strains;
- 55% increase in pta-adhE-pfl-glk
strains.
G. sulfurreducens
(iRM588)
Respiratory
rate
2008 OptKnock
Higher respiratory rate and
increase electron transfer.
Expected decrease in growh.
[189]
E. coli
(iJR904)
Malonyl-CoA 2009 CiED
Specific flavone yields increased by
over 600%.
[147]
S. cerevisiae
(iFF708)
Sesquiterpene 2009
OptGene
85% increase in titer. [197]
MOMA
E. coli
(EcoMBEL979)
Lycopene 2010 FSEOF
Maximum 3.2-fold increase in
lycopene.
[198]
E. coli
(iJR904)
NADPH
availability
2010
CiED - 4-fold increase in leucolyanidin;
[199]
MOMA - 2-fold increase in catechin.
S. cerevisiae
(iFF708)
Vanillin 2010
OptGene
5-fold increase compared to [200]. [201]
MOMA
FVA
MMTa
C. glutamicum
(ATCC 13032)
L-lysine 2011
FluxDesign Nearly 2-fold yield increase
compared.
[202]
EMA to [203]
E. coli
(iJR904)
1,4-butanediol 2011 OptKnock Over 3-fold increase in titer. [190]
E. coli
(iJR904)
Malonyl-CoA 2011 OptForce
- 4-fold increase in intracellular
levels of malonyl-CoA;
[135]
- Highest yield of naringenin in a
lab-scale fermentation ever
achieved.
E. coli
(iAF1260)
Fatty acids 2012 OptForce
Over 20% yield increase among all
the tested strains.
[136]
B. subtilis
(iYO844)
Isobutanol 2012
FluxDesign 61% of maximum theoretical yield,
[204]
EMA a 2.3-fold increase.
S. cerevisiae
(iMM904)
2,3-butanediol 2012 OptKnock
2,3-butanediol titer (2.29 g/L) and
yield (0.113 g/g) under anaerobic
conditions.
[191]
S. cerevisiae
(iMM904)
Succinate 2013 OptGene
30-fold improvement in succinate
titer and 43-fold improvement in
succinate yield compared to the
reference strain.
[205]
a MMT - minimization of metabolite turnover - described in the supplementary material of [201].
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Table 2.3: Industrial patent application/grants of microorganisms, products or processes
referring the use of at least one CSOM.
Description Patent number Year Assignee CSOM Ref
Microorganisms for the
production of adipic acid
and other compounds.
US7799545 B2 2010
Genomatica,
Inc.
OptKnock [192]
Microorganisms for the
production of
1,4-butanediol,
4-hydroxybutanal,
4-hydroxybutyryl-coa,
putrescine and related
compounds, and methods
related thereto.
US20110229946 A1 2011
Genomatica,
Inc.
OptKnock [193]
Primary alcohol producing
organisms.
US7977084 B2 2011
Genomatica,
Inc.
OptKnock
OptStrain
[196]
Microorganisms and
methods for the production
of
1,4-cyclohexanedimethanol.
US20120156740 A1 2012
Genomatica,
Inc.
OptKnock [195]
Cytosolic isobutanol
pathway localization for the
production of isobutanol.
US8232089 B2 2012 Gevo, Inc. OptORF [206]
Microorganisms for the
production of
1,4-butanediol and related
methods.
US8129169 B2 2012
Genomatica,
Inc.
OptKnock [194]
Methods of producing
6-carbon chemicals via
CoA-dependent carbon
chain elongation associated
with carbon storage.
US20130183728 A1 2013
Invista North
America
S.A R.L.
OptFlux
(EA/SA)
[207]
Method for the preparation
of 2,4-dihydroxybutyrate.
WO2014009435 A1 2014
Adisseo
France S.A.S.
CASOP [208]
A microorganism modified
for the production of
1,3-propanediol.
WO2014009432 A2 2014
Institut National
Des Sciences
Applique´es
CASOP [209]
scendants of OptGene, describing a method for producing 6-carbon chemi-
cals [207].
Other heuristic approaches were also experimentally validated by Fowler
and co-workers for the overproduction of malonyl-CoA [147] and by Chemler
and colleagues [199] for the increased availability of NADPH, both in E.
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coli. Fowler’s work culminated in flavone yields increased by over 600%
while Chemler’s translated into a 4-fold increase in leucocyanidin and a
2-fold increase in catechin.
Naturally, validations of gene deletions suggested by CSOMs were the
first to be performed and they were indeed successful up to a certain degree.
However, other more elaborate strategies are not so easy to attain. An obvi-
ous example is the identification of gene amplification/attenuation targets,
which are not necessarily reflected by an increase in the metabolic flux, due
to the complexity of the regulatory machinery. Despite the efforts directed
to this subject, quantitative predictions of the flux distribution following
this type of interventions are still in their infancy. OptReg was specifically
designed for this purpose but has never been experimentally validated.
In fact, the first validation of a method suggesting over/under expression
of genes was performed by Choi for FSEOF [198], revisiting the lycopene
overproduction in E. coli. The FSEOF procedure consists in changing the
objective function of the classic biomass maximization FBA problem, by
considering an additional constraint enforcing the production of the desired
target. The iterative procedure progressively increases the enforced mini-
mum value of the product, while scanning the remaining flux distribution
for relevant flux changes (relatively to the wild-type). The most commonly
changing fluxes are considered preferential targets for manipulation. The
best strain achieved in this work resulted in a 3.2 fold lycopene increase
in comparison with the control strain, and a titer slightly in excess of that
reported by Alper and co-workers [174].
Another of such methods is OptForce, which was promptly validated
in E. coli for the production of malonyl-CoA [135]. OptForce application
was translated into a 4-fold increase in intracellular levels of malonyl-CoA
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and the highest yield of naringenin in a lab-scale fermentation reported.
OptForce was also successfully applied in the E. coli overproduction of
fatty-acids [136], with an overall 20% increase among all the strains.
The last class of methods discussed in this review, EMA-based CSOMs,
has only one member for which experimental validation was performed.
FluxDesign was first validated for the production of L-lysine in C. glutam-
icum where a 2-fold increase in yield was achieved in comparison with an
existing strain [202], and later for the production of isobutanol, where a
strain operating at 61% of the maximum theoretical yield was engineered.
Despite no academic validation has been performed for CASOP, it has
recently been cited in a patent application of Adisseo (Adisseo France S.A.S.
France), describing a method for the preparation of 2,4-dihydroxubutyrate
[208], and another by the Institut National Des Sciences Applique´es (France)
for the engineering of a 1,3-propanediol producing microorganism [209].
Up until recently, EMA-based approaches were limited to small to medium
networks, which forced its application to be subjected to a biased selection
process of the most promising pathway(s), which ultimately hinders the
holistic vision characteristic to systems biology applications.
Overall, however, and despite these successful in vivo applications, the
obtained improvements in yields, productivities and titers are still far away
from the ones obtained with non-rational traditional approaches such as
random mutagenesis. In fact, it has been reported, as an illustrative exam-
ple, over 1000-fold increase on the amount of penicillin produced in Flem-
ing’s original culture of P. chrysogenum [210] by the use of X-Rays, UV rays
or other mutagens since the 1950s. Although this time-span is not compat-
ible with the needs of modern biotechnology, this scale of improvement is
clearly currently unattainable with rational methods.
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One of the reasons for this is clearly the lack of relevant information
in the used models, but it is also difficult to assess where additional de-
velopments should be focused: if in the development of better models, in
simulation methods or in optimization tools, since most validation efforts
are not exploited in sufficient detail. For example, there is a clear lack of
studies that include more than one round of in silico design to in vivo im-
plementation, and where advanced –omics tools are used to characterize the
developed strains, feeding and improving the in silico predictions. In the
future, studies focusing on characterizing in detail the strains constructed
from rational approaches, reporting failed efforts and several cycles of in-
tervention are necessary to assess where the main bottlenecks are. In fact,
since most of the few validation efforts have been reported associated with
specific CSOMs, which would be the final layer of an in silico approach,
it is often impossible to decouple the effects of model predictions from the
CSOM results themselves. More studies are thus needed that would al-
low the separate the validation of GSMMs, simulation tools and CSOMs.
Only to mention an extreme example, the validation of simulation methods
such as FBA, MOMA or ROOM in a large scale has never been performed
apart from the examples used when the methods have been developed or
improved, a gap attributable in part to the scarcity of flux distribution
experimental data.
Other studies that are lacking include the systematic utilization of the
vast amount of information on strains developed using non-rational ap-
proaches to understand if the existing models/simulation/optimization tools
allow to reproduce the successful approaches and what can be learnt from
those strains.
In summary, although improvements are clearly needed in the develop-
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ment of novel CSOM methods that were very scarce until recently, it is
probably also important to focus research efforts on the experimental val-
idation of in silico approaches to foster the adoption of rational tools in
industrial biotechnology.
2.5 Concluding Remarks
The shift from traditional chemical synthesis processes to biotechnological
ones holds the promise to reshape the industrial landscape in the 21st cen-
tury. Essentially driven by energy security and climate changes, the road
towards a bio-based economy still faces several barriers. The investment
in high-risk R&D, infrastructure to support it and guarantees of a steady
and controlled supply of raw materials (mostly agricultural products or
by-products) are among the most sensitive issues to be addressed. An-
other barrier is the public perception towards some biotechnologies, such as
the use of genetically modified microorganisms (GMOs) in agriculture and
food processing. Moreover, the use of farmable land for non-food crops in
a growing world population raises ethical concerns that must be properly
addressed [211]. Current worldwide revenue estimates of biotechnology-
derived goods reach around EUR 60 billion while some predictions for 2030
place this value in nearly EUR 300 billion [211]. The adoption of these
knowledge-based approaches is dependent on global policies supporting the
improvement, validation and scaling-up of these technologies, reducing their
risk and making them more attractive to the industry. In fact, both the
USA with the National Bioeconomy Blueprint [212] and Europe with the
Knowledge-based Bio-Economy (KBBE) program [213] are setting clear ob-
jectives and allocating public resources into these matters.
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While the development and validation of rational-approaches focused on
the development of microorganisms for the production of biofuels and other
bio-based chemicals is evolving steadily, the same cannot be said regarding
agricultural efforts. A clear indicator of this gap is the relative scarcity
of GSMMs in the plant kingdom with reconstructions for only four higher
plants available [214]. The rational engineering of plants for both food crops
and biomass (for other purposes, such as biofuels) will require a stronger
investment both at the economic and at the policy-making levels.
In the various research fronts towards a biobased economy, the devel-
opment of reliable GSMMs, robust phenotype prediction methods and effi-
cient strain optimization algorithms will increasingly become more relevant.
GSMMs and phenotype prediction methods are already used to some extent
in order to guide and evaluate rational engineering efforts [215], although,
as mentioned above, further validation efforts are necessary in both fronts.
Specific limitations regarding the scalability of exact strain optimiza-
tion methods, such as the ones supported by MIP-based or EMA-based
implementations are gradually being dealt with or circumvented by vari-
ous authors. More recently these limitations are becoming more tractable
and a convergence between EMA-based and MIP-based approaches is to be
expected. In fact, Ha¨dicke and Klamt, describe how both the OptKnock
and RobustKnock methods can be reformulated as corresponding cMCS
problems [157].
Another limitation affecting the precision and feasibility of the metabolic
engineering strategies is intimately connected with the lack of kinetic and
regulatory information available and considered in the discussed approaches.
The recently proposed k-OptForce from Chowdhury and co-workers [140]
looks like a step in the right direction. While acquiring kinetic data will re-
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main a difficult problem, already well-know phenomena and parameters can
be exploited by this approach in tandem with the more common stoichio-
metric representations of metabolism, improving the predictive capabilities
of previous methods.
Also within the last decade, a large panoply of methods proposing the
integration of transcriptional data within constraint-based metabolic mod-
els in order to improve the predictive capabilities of flux distributions have
also been proposed [216]. However, the number of CSOMs exploring these
capabilities is still scarce, leaving room for the emergence of new branches
from previously proposed CSOMs or even entirely new ones.
In this review, we presented a highlight of the main computational strain
optimization methods proposed until the today. These methods were seg-
mented into three distinct categories and their functionalities and main
applications were analyzed. As the number of genome-scale reconstructions
increase each year and the complexity of these models is able of capturing
more and more information [217], new methods capable of exploring this
information to generate new knowledge are expected to rise, holding the
promise of finally bridging the gap between the academic-grade efforts and
the industry-grade standards required for a full adoption of CSOMs as a
standard tool for guiding metabolic engineering efforts. Nevertheless, this
adoption is only possible if underlying tools such as modelling and simula-
tion are also further developed and validated.
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chapter 3
MOSTRAIN: AN EVOLUTIONARY MULTI-OBJECTIVE
FRAMEWORK FOR STRAIN OPTIMIZATION
As abundantly described in Chapter 2, the Metabolic Engineering (ME)
arena has been providing advances in strain optimization, through the de-
velopment of methods able to select genetic modifications capable of achiev-
ing an improved production of desired products. As shown, these strain
optimization tasks can be formulated as bi-level problems, adding, over
phenotype prediction, a layer that searches for the best mutant that can be
obtained by performing genetic alterations to the wild type. The most stud-
ied problem consists in discovering a subset of genes to delete to achieve
strains that maximize an objective function (e.g. yield) related with the
production of a target compound, while keeping the host viable. Differ-
ent approaches were proposed, namely OptKnock that uses MILP [1] and
meta-heuristics such as Evolutionary Algorithms (EAs) [2] and Simulated
Annealing (SA) [3].
Although these approaches have provided good results, they are still
limited since they usually return a single solution to the problem or, in
some cases, sets of solutions with limited variability.
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3.1 Introduction
Among all the previously discussed methods, EAs provide the most diverse
solutions, but typically those follow similar strategies to maximize the se-
lected objective function. In order to overcome these limitations, informa-
tion from multiple criteria is often included in a single objective function.
However, these aggregation techniques can introduce undesired biases in
the sampling process.
In this context, we here propose the use of multi-objective approaches
to provide strains with different trade-offs between the distinct factors in-
volved. For ME applications, it is relevant to find, for example, different
trade-offs between the production capability regarding the desired com-
pound, the strain viability (measured by the biomass flux) or the predicted
cost of implementing the genetic modifications.
In this work, an approach based on Multi-Objective Evolutionary Al-
gorithms (MOEAs) is thus proposed. Since the mid-1980s, MOEAs have
been used to solve multiple criteria problems in distinct scenarios and the
nature of the ME problem suggests they can be good candidates here. The
MOEA chosen for this task is one of the best performers in the field, the
Strength Pareto Evolutionary Algorithm 2 (SPEA2) [4]. Other algorithms,
such as the Non-dominated Sorting Genetic Algorithm II (NSGA-II) [5],
were tested in preliminary experiments with not so satisfactory results (not
shown).
The approaches are validated with three case studies considering the
production of succinate, lactate and pyruvate using E. coli as the host
in aerobic and anaerobic conditions. Two scenarios were tested: in the
former, two objectives are set including the maximization of the production
of the compound of interest and maximization of biomass production; in
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the latter, a third objective is added: the minimization of the number of
gene knockouts.
The overall results show that MOEAs were able to find a set of trade-
offs between the two or three optimization aims more effectively than single-
objective algorithms, discovering more diverse solutions. Also, we show that
the quality of the solutions is comparable or superior even when using an
aggregation function in single objective EAs. All the proposed methods are
implemented in a plug-in for the OptFlux platform [6], an open-source, user-
friendly software for ME, and thus can be freely used by the community.
3.2 Methods
3.2.1 Multi-objective optimization
The complexity of many optimization problems is often difficult to represent
using a single objective. Therefore, multi-objective (MO) optimization ap-
plications have been increasing and the development of suitable algorithms
has been an active area of research. In MO problems, there is no longer
a single optimal solution, but rather a set of solutions of non-comparable
quality. In this context, some definitions need to be put forward:
The classical definition of a multi-objective optimization problem can
be formally written in the form: minimize[f1(x), f2(x), . . . , fK(x)] where
fi : Ω→ RK are K objective functions. The task is to determine from the
set of feasible solutions, the particular subset yielding optimum values for
all objective functions [7]. Yet, it is very rare to find a solution that simul-
taneously optimizes all objective functions. Therefore, we usually seek the
optimal set of trade-offs (Pareto Optimal Front), rather than a single solu-
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tion. This clearly changes the concept of ”optimality” to the one proposed
by Pareto [8], working as described in the following definitions.
Definition 1 Parameter Space and Fitness Space: The set of all solutions
to the optimization problem is known as the Parameter Space or Solution
Space. The Feasible Region, Ω, is the set of all admissible solutions to the
problem where all the constraints are satisfied. The solution space is pro-
jected onto a K-dimensional Fitness Space, by the K objective functions.
Definition 2 Dominance: A solution a ∈ Ω is said to dominate another
solution b ∈ Ω, when ∀i : fi(a) ≤ fi(b) and ∃i : fi(a) < fi(b), where fi is
the i -th objective (assuming a minimization problem without losing gen-
erality). This relation is notated as a ≺ b. In a less formal manner, a
solution a dominates another solution b, if a is not worse than b in any of
the objectives and it is at least better in one.
Definition 3 Pareto Optimality : A solution x ∈ Ω is Pareto Optimal, if
@ w ∈ Ω such that w ≺ x. The set of all the Pareto Optimal solutions is
called Pareto Optimal Front (notated as Ptrue in the solution space and as
PFtrue in the fitness space). Since it is usually impossible to find Ptrue or
PFtrue, an approximation is taken. Thus, to evaluate a given solution set
S, there is the need to specify an artificial or desired solution set termed
Reference Set, notated as R.
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3.2.2 Multi-objective and Single-objective
Algorithms
Evolutionary Algorithms (EAs) [9] are a popular family of metaheuristic
optimization methods, inspired in biological evolution through natural se-
lection. They work by evolving a set of individuals encoding solutions to
a given problem. Each individual is evaluated via a fitness function that
assigns a numerical value to it, depending on the quality of the solution.
New solutions are created using reproduction operators over selected par-
ents taken probabilistically from the current population.
On the other hand, Simulated Annealing (SA) [10] works in a distinct
fashion, keeping just one solution. This is used to create new solutions
through the application of a mutation operator. Each time a new solution
is created, it replaces the original one, if it is better or, in some cases, even
when it is worse. The probability of accepting worse solutions depends on
the difference between the fitness values and the current temperature, a
variable that is reduced as the SA iterates.
In previous work by the authors, both algorithms have been proposed
to address strain optimization problems, selecting (near-)optimal sets of
genes/ reactions to delete from a model, to overproduce a given compound.
Both used the same representation, the set-based representation presented
in the next section. The full configuration of these algorithms and the
results obtained can be found in [3].
The populational and stochastic nature of EAs enables them to find sev-
eral possible members of the Pareto-front in a single run. It must be noted,
however, that to properly work in multi-objective scenarios, a new class of
MOEAs has been proposed which, while keeping the main principles, in-
troduce some changes into the selection and re-insertion steps. Typically,
Paulo Maia University of Minho, 2015
An EMO Framework for Strain Optimization| 97
MOEAs keep sets of solutions that are Pareto optimal. The first MOEAs
were developed in [11], soon followed by several approaches developing more
specialized EAs. One advantage of using MOEAs over other MO optimiza-
tion methods lies in the few constraints imposed over the objective function
(e.g. they do not depend on the continuity of the Pareto-front). Also, they
are relatively easy to implement, very robust and can be easily adapted to
parallel computing. A general idea of MOEAs and the recent history of the
field can be found in [12].
In this work, the SPEA2 [4] was tested, an evolution of the previous
SPEA [13] algorithm. SPEA uses an external archive that contains non-
dominated solutions (called the external non-dominated set). At each gen-
eration, non-dominated individuals are copied from the population to this
external non-dominated set. For each individual in the archive, a strength
value, proportional to the number of solutions in the archive it dominates, is
computed. The fitness of each individual in the current population is com-
puted according to the strengths of all external individuals that dominate
it. This strategy is used to promote the convergence of the algorithm. The
fact that the external non-dominated set is used in the selection process
brings the problem that, if that set grows too much, the selection pressure
might be reduced, thus slowing down the global search process. To prevent
this, a clustering technique called ”average linkage method” was adopted
to prune the external non-dominated set, thus maintaining diversity.
To allow the fairer comparison of the algorithms, some changes were ap-
plied to the EA and SA algorithms, regarding the information that is kept
during each run, without compromising their procedure nor interfering with
the way they search for solutions. The major change was the implementa-
tion of an archive that keeps the best solutions found by the EA and SA
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during the run. This is not used by the algorithms to select or create new
solutions, but allows to build a Pareto-front with the solutions found during
their execution. The archive has a maximum size, being managed using the
same methods provided in SPEA2, including methods for selecting solutions
for removal when the maximum size is reached.
The structure of the 3 algorithms, EA, SA and SPEA2, used in this work,
is depicted in Figure 3.1, in an attempt to highlight their major features.
Extended details about the implementation can be found in Section 5.4.
3.2.3 Representation scheme and operators
The optimization problem addressed here consists in selecting, from a set
of genes of an organism (represented in the respective metabolic model), a
subset to be deleted, in order to optimize a set of objective functions.
The encoding of a solution is achieved by a set-based representation
[3], where only gene deletions are represented. The representation scheme
uses variable-sized solutions and hence sets with distinct cardinalities can
compete within the search process.
Two types of reproduction operators were used: crossover and mutation.
The first is inspired on uniform crossover and works as follows: the genes
that are present in both parent solutions are kept in both offspring solutions;
the genes that are present in only one of the parent solutions are sent to
one of the offspring solutions, selected randomly with equal probabilities
(used in EA and SPEA2).
Regarding mutation, three operators were used: random mutation re-
places a gene in the solution by another gene in the allowed range; grow
mutation introduces a new gene into the solution, whose value (index) is
randomly generated (avoiding duplicates in the set) and shrink mutation:
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Figure 3.1: Overview of the developed algorithms. The upper region shows the major
steps of the three algorithms (See details in 5.4.1, 5.4.3 and 5.4.2). The evaluation
gray box illustrates the processes of solution decoding, from Gene Knockout Sets (GKS)
to Reaction Knockout Sets (RKS) (upper-left), phenotype simulation showing the added
constraints (bottom) and fitness evaluation (details in 5.4.4) for both MO and SO cases
(upper-right).
removes a randomly selected gene (these are used in EA, SA and SPEA2).
3.2.4 Solution decoding and evaluation
Each solution is represented as a gene knockout set GKSi,t (i-th solution
of the population at generation t) containing a list of indexes for genes
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in the model, a subset of the full set of genes that can be deleted (essen-
tial genes are not allowed). Transcriptional/ translational information is
encoded in the model as a set of Gene-Reaction (GR) associations, repre-
sented by Boolean rules, including AND and OR operations. Each GKS is
converted through those rules into a reaction knockout set (RKSi,t). Each
RKS consists of a set of integer values between 1 and N , where N is the
number of reactions in the model. When simulating this solution, for each
reaction in this set, the flux is forced to be 0, therefore disabling it from
the model.
The process proceeds with the phenotype simulation of the mutant using
one of the available methods. In the experiments performed within this
work, the FBA method was used, but any of the methods available within
the OptFlux framework can be used with this MO framework (e.g. MOMA
or ROOM).
FBA is a constraint-based approach where feasible flux distributions are
mainly defined by three types of constraints (Equation 1b): i) stoichiometric
constraints, defining the mass balance equations over internal metabolites
assuming steady-state (in the formulation vj corresponds to the flux of
reaction j and Sij, stands for the stoichiometric coefficient of metabolite i
in reaction j); ii) thermodynamic or capacity constraints, mainly defining
reaction reversibility (vj,min for the lower limit and vj,max for the upper
limit of the reaction vj); and iii) those imposed by the knockouts defined in
the respective RKS. FBA uses linear programming to determine the optimal
flux distributions using a specified objective function, usually corresponding
to the maximization of a flux representing biomass production.
The overall optimization problem addressed in this work can be formu-
lated as:
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a)
{
max fi,∀i ∈ k
(1)
subject to:
b)

max fbiomass
subject to:
i) Stoichiometric constraints∑N
j=1 Sijvj = 0,∀i ∈ {1, ..,M}
ii) Thermodynamic or capacity constraints
vj,min ≤ vj ≤ vj,max,∀j ∈ {1, .., N}
iii) Knockout constraints
vj = 0,∀j ∈ RKS
where N corresponds to the set of reactions and M to the set of metabo-
lites in the model. The layer (a) addresses the objective functions at the
bioengineering level to be addressed by the MO algorithm, while the layer
(b) depicts the objective function and constraints of the inner phenotype
simulation (cellular level). In this bi-level formulation, the strain optimiza-
tion and the phenotype simulation methods can be chosen independently
from all available options (e.g. SPEA2, EA or SA in a) and FBA, pFBA,
MOMA, LMOMA, ROOM or MiMBl in b)).
The output of the phenotype simulation is the set of flux values for all
reactions in the model. These are used by the optimization algorithms to
compute the fitness value of the solution, using an appropriate objective
function. One possible objective function is the Biomass-Product Coupled
Yield (BPCY) [2], given by PB
S
, where P stands for the flux of the desired
product; B for the biomass flux and S for the substrate uptake flux. Be-
sides optimizing for the production of the desired compound, it also allows
to select mutants that exhibit high growth rates, i.e., that are likely to ex-
hibit a higher productivity. An overview of the full framework for solution
evaluation is depicted in the respective box of Figure 1.
In this work, when dealing with multi-objective problems, we seek for
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solutions optimizing three different objective functions - (OF1) the value of
the flux of the compound of interest (P), (OF2) the biomass flux value (B)
and (OF3) a function representing the cost of implementing the solution
(aims at minimizing the number of knockouts) given by 1
s+1
, where s is the
number of gene knockouts (size of the solution).
3.2.5 Case studies and experimental setup
Three case studies were used to test the aforementioned algorithms consid-
ering the bacterium Escherichia coli in the production of succinate, lactate
and pyruvate in both aerobic and anaerobic conditions.
Succinate is one of the key intermediates in cellular metabolism and
therefore an important case study for ME [14]. Succinate and its derivatives
have been used to synthesize polymers, as additives and flavouring agents
in foods, supplements for pharmaceuticals, or surfactants. Currently, suc-
cinate is produced through petrochemical processes that can be expensive
and have significant environmental impacts. The knockout solutions that
lead to an improved production are not straightforward to identify since
they often involve a large number of interacting reactions [15].
On the other hand, lactate and its derivatives have been used in a wide
range of food processing and industrial applications like meat preservation,
cosmetics, oral and health care products and baked goods. Additionally,
and because it can be easily converted to readily biodegradable polyesters,
it is emerging as a potential material for producing plastics from sugars.
The commercial demand for pyruvate has been increasing due to the
variety of fields where it is applicable. It is currently used as a dietary
and weight control supplement [16], nutraceutical [17] and antioxidant [18].
Moreover, because it possesses both reactive ketonic and carboxyl groups,
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its applications as a starting material are widespread to the chemical, agro-
chemical and pharmaceutical industries [19–21].
E. coli has many advantageous characteristics as a production host, such
as rapid growth and simple nutritional requirements. The iAF1260 E. coli
genome-scale metabolic model used in this work was developed by [22]. This
model includes a total of N=2078 reactions, M=1369 metabolites and 1260
genes. To reduce the algorithm’s search space, a pipeline of operations to
identify possible knockouts targets was applied. This includes steps to iden-
tify fluxes mathematically constrained to zero, as well as equivalent fluxes
as described in [3]. Further restrictions to the number of genes available as
possible knockout targets were also applied following the pipeline described
in [23]. This process resulted in a list of 250 and 223 variables (genes) to
be considered by the optimization algorithms, for the aerobic and anaero-
bic case studies, respectively. For all the case studies, the glucose uptake
flux was limited to a maximum of 20 mmol.gDW−1.h−1 and the oxygen
uptake flux, in the aerobic case studies, was limited to a maximum of 20
mmol.gDW−1.h−1.
For all algorithms, the termination criterion for each run was defined
based on a maximum of 50000 solution evaluations. The initial solutions
are sets with randomly generated elements. The size of the individuals is
randomly created in the range [1,20]. For each experimental setup, the
process was repeated for 30 runs. The archives’ maximum size was set to
100 solutions. A typical run of these algorithms, using this model after the
pre-processing stages is executed in approximately 30 minutes in common
Intel i7 CPU.
In the implementation of the phenotype prediction methods in this work,
IBM ILOG CPLEX was used to run the simplex algorithm for linear pro-
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gramming.
3.2.6 Performance metrics
Although the comparison between Pareto fronts is not a straightforward
task, some metrics have been developed enabling to better evaluate the
quality of the solutions and compare the performance of the algorithms.
The definition of quality in MO optimization involves a number of opti-
mization goals: the distance of the resulting set to the reference set should
be minimized; a good distribution of the solutions along the front should be
obtained; and, the spread of the front should be maximized, i.e., for each
objective, a wide range of values should be covered. In this work, three
Performance Indexes (PIs) were used. In the following definitions, PFknown
refers to the experimental Pareto-front being tested in each instant and R
to the reference set that is used to approximate the true optimal Pareto
front (calculated in this work as explained in the next section).
• Generational Distance (GD) [24]: This metric calculates how far,
on average, the experimental pareto front (PFknown) is from R. It is
mathematically defined by:
GD , (
∑n
i=1 d
K
i )
1
K
n
(3.2)
where n is the number of solutions in PFknown, K is the number
of objectives and di is the distance in the fitness space (Euclidean
Distance when K=2) between each solution and the nearest member
in the reference set R.
• Hypervolume (HV) [13]: This indicator is defined as the area of
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coverage of PFknown with respect to the objective space (in a bi-
objective problem). Its mathematical definition can be interpreted
as the sum of all the rectangular areas (volumes, hypervolumes,...)
bounded by the solutions and (f1(x),f2(x),...,fK(x)) for aK-objectives
problem:
HV ,
{⋃
i
voli|soli ∈ PFknown
}
(3.3)
where voli is the calculated volume (area, hypervolume, ...) corre-
spondent to each solution soli contained in PFknown.
• C-Measure (C) [25]: It is based on the concept of solution domi-
nance. Given two PFs (PF1, PF2) the measure C(PF1, PF2) returns
the fraction of solutions in PF2 that are dominated by at least one so-
lution in PF1. Values near 1 clearly favor the method that generated
PF1; values near 0 show that few solutions in PF2 are dominated by
solutions in PF1.
3.2.7 Generation of reference sets
One difficulty that arises in the comparison of multi-objective algorithms is
the fact that the optimal Pareto set is not known a priori and is typically
impossible to calculate. Thus, the alternative is to build a reference set (R)
that can work as an approximation.
The strategy followed was to synthetically generate these reference sets
by defining maximum theoretical values. Note that a large part of this space
can be unreachable in practice. The process of reference set generation
followed these steps:
• Compute the biomass flux value for the wild-type (via FBA simulation
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without further constraints);
• Constrain the minimum biomass allowed to a percentage of the pre-
viously computed wild-type biomass. These percentages were varied
in the range [0, 100]% in 0.05% steps. For each, an FBA maximiz-
ing the respective product was performed. This allowed to generate a
reference set with 2001 points for each of the bi-objective case studies;
• To generate the reference set for the tri-objective case studies, and
since an approach similar to the previous one would not be reasonable,
we simply extended the previous reference set along the third objective
axis (repeating R for each of the number of knockouts in the range
[0, 20]). This resulted in reference sets composed of 42021 points for
each of the tri-objective case studies.
Furthermore, aggregated PFs for each algorithm in each case study were
also created. This was accomplished by assembling the PFs for each algo-
rithm in each case study, encompassing all non-dominated solutions reached
by that algorithm in all the runs. This process implies taking the final
archives from each run, simplifying its solutions (removing genes not con-
tributing to the objective functions), creating its union (which removes
repetitions) and removing all dominated solutions from this set. An extra
step was also used to discard all non-robust solutions from these sets. A
solution is considered robust, if, by enforcing the biomass to be at least
99% that of the solution (via an additional constraint) followed by an FBA
minimizing the target product, the production of that compound is still
predicted.
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3.3 Results and Discussion
3.3.1 Results for product and biomass optimization
The first set of experiments considered the simplest scenario: two objective
functions, OF1 and OF2, as defined above. Thus, the objective was to
find trade-offs between the capacity of the strain to produce the target
compound and its predicted viability. SPEA2 will be compared with the
single objective EA and SA [3], including the adaptations described above.
In both, a single objective function has to be employed, an aggregation
function combining both objectives. The option was to consider the product
of OF1 and OF2 (equivalent to the BPCY defined above when the substrate
uptake is fixed).
The first analysis concerns the size of the PFs generated by each algo-
rithm, for each case study. The sizes of the synthetically generated reference
sets, as well as aggregated PFs for each algorithm can be found in Table
3.1.
Table 3.1: Size of the reference sets (synthetic) and the aggregated Pareto fronts (for
each algorithm) in all the bi-objective case studies.
Reference SPEA2 EA SA
Aerobic
Succinate 2001 60 5 58
Lactate 2001 910 181 265
Pyruvate 2001 746 360 542
Anaerobic
Succinate 2001 162 95 94
Lactate 2001 924 119 205
Pyruvate 2001 326 68 128
This provides a first result, showing that SPEA2 fronts are larger and
thus this algorithm is able to obtain more non-dominated solutions. How-
ever, this does not guarantee their diversity. The visualization of the PFs
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for each algorithm provides an important analysis tool. These are displayed
in Figures 3.2 that show the ability of SPEA2 to find a good set of non-
dominated solutions that are near the reference set, and well distributed
along the Pareto front.
These visual conclusions are further reinforced looking at the results
from the application of the defined metrics to the results (compiled in Tables
3.2 and 3.3). In this analysis, note that for GD smaller values are better,
while for HV, higher values are preferable. For the C-measures, lower values
in the columns (dominated) and higher values in the rows (dominating) are
preferable. For all the case studies the advantage of SPEA2 is clearer,
obtaining the best results in nearly all the PIs (Table 3.2) and also having
significantly lower counts of dominated solutions (Table 3.3). The only
exceptions to this trend occur for the aerobic production of pyruvate case
study with the SA algorithm and the aerobic production of succinate with
the EA algorithm. However, since the GD metric calculates the average of
the distance of the solutions to the reference, if a given case study has few
solutions but those solutions are good, the metric can be deceptive.
Table 3.2: Performance Indexes for the bi-objective case-studies. For each case, the best
performance is shown in bold.
Aerobic Anaerobic
GD HV GD HV
Succinate
SPEA2 0.00690 0.43994 0.00495 0.50041
EA 0.00237 0.05625 0.01111 0.38252
SA 0.01296 0.28224 0.00565 0.47497
Lactate
SPEA2 0.00269 0.57577 0.00006 0.67455
EA 0.00375 0.54422 0.00016 0.65317
SA 0.00336 0.54524 0.00010 0.65331
Pyruvate
SPEA2 0.00130 0.63765 0.00672 0.44947
EA 0.00150 0.56707 0.01405 0.44044
SA 0.00111 0.56397 0.00675 0.44903
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Figure 3.2: Coverage plots for the bi-objective case studies in aerobic (a) and
anaerobic (b) conditions, showing the PF of each method overlaying the global
reference front R (in black). Areas not covered (black) show regions where the
method did not reach optimal solutions (as compared to R). White dots represent
solutions.
An alternative view is provided by Figure 3.3, where all methods are
evaluated measuring their capacity to generate good solutions both in the
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Table 3.3: C-Measures for the bi-objective case studies. For each case, the best perfor-
mance is shown in bold.
Aerobic Anaerobic
SPEA2 EA SA SPEA2 EA SA
Succinate
SPEA2 40.00% 74.14% 92.63% 39.36%
EA 1.67% 0.00% 3.70% 5.32%
SA 0.00% 40.00% 20.99% 89.47%
Lactate
SPEA2 49.72% 34.34% 19.33% 20.98%
EA 3.30% 15.09% 3.35% 22.93%
SA 3.96% 53.04% 5.19% 44.54%
Pyruvate
SPEA2 30.28% 20.30% 54.41% 25.78%
EA 7.91% 18.45% 3.99% 3.91%
SA 8.58% 36.11% 12.58% 58.82%
perspective of an aggregation function, in this case the BPCY, and the sub-
strate to product carbon yield (CYIELD). For each run of each algorithm,
the solution in the final archive that maximizes the BPCY and the solu-
tion that maximizes the CYIELD are taken. Boxplots showing these values
for each algorithm and case study are presented. The results show that the
SPEA2 is able to perform at a comparable, if not better, level in this regard.
This shows its ability to find good overall solutions in the perspective of a
single objective evaluation function, even if it is not directly maximizing it,
as it is the case with EA/SA.
Another way of measuring the performance of the various algorithms is
presented in Figure 3.4, depicting the best solutions (highest BPCY and
highest CYIELD respectively - y-axis) found by the algorithms, given a
maximum number of allowed gene deletions (x-axis).
Despite not being configured to optimize neither of the objective func-
tions, the SPEA2 results are on par with the ones reached by the EA and
SA algorithms for the BPCY objective function (superior in the aerobic
production of succinate). For the CYIELD objective function, the SPEA2
Paulo Maia University of Minho, 2015
An EMO Framework for Strain Optimization| 111
(a) BPCY
succinate lactate pyruvate
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
0.0
0.3
0.6
0.9
1.2
0.0
0.2
0.4
0.6
a
e
robic
a
n
a
e
robic
SPEA2 EA SA SPEA2 EA SA SPEA2 EA SA
BP
CY
(h−
1 )
(b) CYIELD
succinate lactate pyruvate
ll
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
0.00
0.25
0.50
0.75
1.00
0.00
0.25
0.50
0.75
1.00
a
e
robic
a
n
a
e
robic
SPEA2 EA SA SPEA2 EA SA SPEA2 EA SA
Ca
rb
o
n
yie
ld
(C
−
m
m
o
l
C
−
m
m
o
l)
Figure 3.3: Boxplots for the bi-objective case studies, representing both (a) the
best BPCY (mmol product . mmol substrate−1 . h−1) and (b) the best CYIELD
(C −mmol product . C −mmol substrate−1) obtained in each run.
results are visibly superior. It is interesting to note that overall BPCY best
results are achieved by all algorithms, except for the succinate case study,
even though only EA and SA specifically search for the best BPCY. When
looking at the CYIELD result, for which none of the approaches directly
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Figure 3.4: Monotonic plots for the bi-objective case studies, showing (a) the
best BPCY (mmol product . mmol substrate−1 . h−1) and (b) the best CYIELD
(C −mmol product . C −mmol substrate−1) obtained by each algorithm, as a
function of the number of gene deletions.
optimizes for, only SPEA2 seem to be able to find the best overall solutions
in the 3 case studies, meaning that SPEA2 results are sufficiently diverse to
be able to include good solutions independently on the evaluation criteria.
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It is worth remembering that all the solutions (for all the algorithms)
have been previously simplified, thus removing all the genes not contribut-
ing directly to the original objective functions (OF1 and OF2), reducing
their effective sizes.
3.3.2 Minimizing the number of knock-outs
Minimizing the number of gene knock-outs is an important objective when
considering strain optimization approaches, given that the practical im-
plementation of a gene deletion is both time and economically demanding.
Also, wet-lab implementations of mutant strains with many knock-outs may
be very difficult tasks. So, we took this aim as the third optimization objec-
tive, adding OF3 to the list of functions to maximize. The three algorithms
were again executed, considering only the aerobic case studies. The aggre-
gation function used in the case of EA and SA (single objective algorithms)
is still the product of the three values (in this case OF1, OF2 and OF3).
The size of the reference sets and aggregated PF is presented in Table 3.4.
Table 3.4: Size of the reference sets (synthetic) and the aggregated Pareto fronts (for
each algorithm) in the tri-objective case studies.
Reference SPEA2 EA SA
Aerobic
Succinate 42021 79 9 9
Lactate 42021 908 60 153
Pyruvate 42021 1231 294 244
Tables 3.5 and 3.6 show the results for the calculation of the same set of
metrics used in the previous case. It is clear that, in this case, the advantage
of the SPEA2 is even more pronounced than before. In this case, the only
exception happens in the succinate case study, where both the EA and SA
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algorithms have a better GD value, which is easily explained by the very
low number of solutions that they found.
Table 3.5: Performance Indexes results for the aerobic, tri-objective studies.
Aerobic
GD HV
Succinate
SPEA2 0.01238 0.03072
EA 0.00066 0.00989
SA 0.00114 0.00790
Lactate
SPEA2 0.00261 0.07852
EA 0.01238 0.07187
SA 0.00610 0.05772
Pyruvate
SPEA2 0.00101 0.11064
EA 0.00152 0.09928
SA 0.00168 0.07734
Table 3.6: C-Measures for the aerobic, tri-objective case studies.
Aerobic
SPEA2 EA SA
Succinate
SPEA2 33.33% 44.44%
EA 0.00% 0.00%
SA 3.80% 22.22%
Lactate
SPEA2 41.67% 26.14%
EA 2.09% 18.30%
SA 2.64% 11.67%
Pyruvate
SPEA2 27.89% 38.52%
EA 5.77% 46.31%
SA 3.41% 14.97%
The monotonic plots for the tri-objective case studies are presented in
Figure 3.5. Here, the quality of the SPEA2 results can further be confirmed,
since it is the algorithm with the best overall behavior, able to obtain the so-
lutions with both the highest BPCY and highest CYIELD, for each number
of gene deletions.
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Figure 3.5: Monotonic plots for the tri-objective case studies, showing (a) the
best BPCY (mmol product . mmol substrate−1 . h−1) and (b) the best CYIELD
(C −mmol product . C −mmol substrate−1) obtained by each algorithm, as a
function of the number of gene deletions.
Visualizing the non-dominated fronts when working with more than 2
objectives becomes a harder task. To try to address this issue, in Figures 3.6
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(succinate production), 3.7 (lactate production) and 3.8 (pyruvate produc-
tion), 3D plots of the PFs are displayed showing only comparisons of pairs
of algorithms to foster interpretability. For each case study, we show the
comparison of SPEA2 with the other algorithms. For each pair, both the
3D plot and the projection to the biomass and product (either succinate or
lactate) axes are provided. One conclusion that arises almost immediately
is the higher number of non-dominated solutions available for the SPEA2
algorithm.
From the projections, one can also assert that the coverage of the solu-
tion space for biomass and product is, once again, superior in the SPEA2
case. Duly note that the extreme solutions are always covered by the SPEA2
algorithm even though an extra objective has been added. From the 3D
plots it is also possible to observe that SPEA2 is capable of reaching similar
solutions in terms of biomass and product fluxes, with a smaller number
of knock-outs, when compared to the SO alternatives. These conclusions
are reinforced by the solutions displayed in Table 3.7 that shows the best
overall and 6 knock-out solutions in terms of carbon yield.
In the table, three solutions are presented in more detail (s1, s2 and
s3) corresponding to the best solutions found by SPEA2 for a maximum
of 6 knock-outs. We can easily observe that the fitnesses of these solutions
are either equal or better than the best overall solutions found by the other
algorithms. Moreover, the best overall fitnesses for the SPEA2 algorithm
are always better than the ones obtained by the other algorithms, even if
it requires more deletions, demonstrating the superior sampling prowess of
the MO approach. Another interesting observation is that all the genes that
compose solution s1 (succinate) are among the top 10 genes for the same
problem presented in Table 3.8.
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It is interesting to observe that, from the top 10 genes present in solu-
tions that reach at least 75% of the maximum BPCY, a very small subset
is kept when we added the third objective function. This suggests that the
core mechanisms underlying the top solutions has shifted significantly.
The full analysis of all (or a significant part) of the solutions obtained
is impossible in this scope (even because of its diversity). Thus, we pro-
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Figure 3.6: 3D scatter plots for the aerobic succinate production case study. In
each, SPEA2 solutions (red asterisks) are plotted against either EA (top) or SA
(bottom) solutions (blue circles). The projections for each problem are always
presented on the left side of the full Pareto-front. From these projections, the
wider distribution and spread of SPEA2 fronts becomes evident.
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vide in supplementary material a list of all non-dominated unique solutions
obtained by each algorithm in both studies and considering the 2 and 3
objective scenarios. This list is given in a spreadsheet, including for each
solution the number and list of gene deletions, as well as the product and
biomass flux values obtained in the FBA simulation (BPCY and some other
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Figure 3.7: 3D scatter plots for the aerobic lactate production case study. In each,
SPEA2 solutions (red asterisks) are plotted against either EA (top) or SA (bottom)
solutions (blue circles). The projections for each problem are always presented on
the left side of the full Pareto-front. From these projections, the wider distribution
and spread of SPEA2 fronts becomes evident.
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auxiliary objective functions’ values are also given). Taking advantage of
the sorting features of the spreadsheet it is possible to quickly find solutions
using desired criteria.
While trying to understand the biological validity of the solutions pro-
posed by the algorithms, we have analysed knockout solutions provided in
literature that were implemented in vivo, which have been achieved with-
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Figure 3.8: 3D scatter plots for the aerobic pyruvate production case study. In
each, SPEA2 solutions (red asterisks) are plotted against either EA (top) or SA
(bottom) solutions (blue circles). The projections for each problem are always
presented on the left side of the full Pareto-front. From these projections, the
wider distribution and spread of SPEA2 fronts becomes evident.
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Table 3.7: Best CYIELDs for the tri-objective case studies. Fitnesses considering a
maximum of 6 knock-outs are also displayed.
Best (K) Best 6K
Succinate
SPEA2 0.45988 (13) 0.25596 (s1)
EA 0.06494 (6) 0.06494
SA 0.06494 (6) 0.06494
Lactate
SPEA2 0.74562 (20) 0.60148 (s2)
EA 0.60616 (7) 0.60148
SA 0.60298 (7) 0.58122
Pyruvate
SPEA2 0.96989 (19) 0.74569 (s3)
EA 0.63323 (18) 0.61239
SA 0.65368 (6) 0.65368
(s1) maeB - pntB - sdhA - aldB - gnd - edd
(s2) gldA - sdhD - ppc - pflA - lpd - pflC
(s3) sdhC - poxB - pflA - lpd - pflD - gnd
Table 3.8: Most frequently selected genes (in () the percentage of solutions where they
appear). List with the 10 most frequently selected genes for deletion for the SPEA2
algorithm in the succinate case study, both for the 2 and 3 objectives approaches, when
considering solutions able to reach at least 75% of the top BPCY for that case study.
The full list for all algorithms and case studies can be accessed in the supplementary
material.
Aerobic
2 objectives 3 objectives
Succinate
pntA (100.00%) pntB (100.00%)
maeB (100.00%) gnd (100.00%)
pykA (100.00%) aldB (100.00%)
pykF (100.00%) sdhA (91.89%)
zwf (100.00%) maeB (91.89%)
maeA (96.30%) eda (62.16%)
eda (96.30%) serA (59.46%)
fsaB (74.07%) sucC (45.95%)
fsaA (74.07%) edd (43.24%)
gcvH (48.15%) scpC (40.54%)
out the help of this type of algorithms, rather by the knowledge of experts.
The first problem we had to deal with is related with the few number of
solutions that have been implemented in vivo in any of the case studies.
Nevertheless, we have chosen the succinate case study to analyse, since
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it is the most difficult one for all the algorithms. The results from this
analysis can be found in the supplementary material (Excel spreadsheet
chapter3 literature mutants.xlsx ).
We also realized that often the conditions of in vivo studies were not
the ones chosen in our optimization (e.g. many of the studies available
are in anaerobiosis), and also that several of the targets implemented in
vivo are not accounted for in our model (e.g. regulatory proteins) or are
considered essential in the model due to incompleteness of information (icd
or ptsG). These factors, allied to the fact that, as observed in vivo, there
seems to be a great diversity of genetic mutations that originate high per-
forming mutants (as shown in the supplementary material), explains why
there is not a perfect match between the best solutions we found and the
ones implemented so far. Nevertheless, it is still possible to conclude that
many of the common in vivo targets were also found by our algorithm in
several solutions. Examples of those genes are the obvious sdh (codifying
for succinate dehydrogenase), pta (phosphate acetyltransferase) or poxB
(pyruvate oxidase) that, besides interrupting the TCA cycle (sdh), avoid
the formation of the main competing carbon sink (acetate, produced either
by poxB or pta/ackA).
On the other hand, the variety of solutions found by our algorithms
is much broader than what can be found implemented in vivo, which is
natural given the disproportion between the number of in vivo and in silico
solutions. An interesting outcome is the realization that these algorithms
provide a great diversity of solutions expected to have different compromises
between different objectives that have not yet been exploited commercially.
Examples of such non-intuitive targets are related with the replacement of
the common serine and glycine biosynthesis (knockout of genes glyA - ∼
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20% of the solutions - and serA/serB - ∼ 60% of the solutions) by synthesis
via threonine, promoting a higher flux through the glycolysis and the TCA
cycle. Although this approach still needs validation, similar approaches
involving the aminoacids metabolism have been highlighted for S. cerevisiae
[2].
3.4 Conclusions
In the Metabolic Engineering arena, the possibility of selecting the appropri-
ate genetic modifications to a given microorganism offers a lot of promises.
However, either due to lack of information or incorrect assumptions, the
uncertainty of the results provided by the current approaches renders some
of the solutions unfeasible. Here, we propose the MOStrain framework that
provides a very attractive approach for strain optimization tasks, given its
ability to find high quality solutions, as well as providing in a single run a
set of alternatives that can be explored by the ME experts.
Future improvements, currently in development, include the ability to
use local optimizers over a selected region of the Pareto-front computed by
the framework, as well as the inclusion of over/under expression of genes as
optimization targets [26]. Another extension will allow to account for both
metabolic and regulatory information during the optimization process [27]
Also, user-friendly tools are being developed to foster the visualization and
interpretation of the solutions before their wet-lab implementation, aiming
at the understanding of the strategies found by mutant strains to achieve
the overproduction of the compounds of interest.
Paulo Maia University of Minho, 2015
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chapter 4
IDENTIFICATION OF ROBUST STRAIN DESIGNS VIA
MULTIPLE PHENOTYPE PREDICTION
As it has been described in Chapter 2, the past two decades have wit-
nessed great advances in the computational modeling and systems biology
fields. Soon after the first models of metabolism were developed, several
methods for the prediction of phenotypes were also put forward. With the
ever-growing information provided by such methods, new questions arose.
Metabolic Engineering in particular posed some interesting questions. Re-
cently, Schuetz and co-workers proposed that the metabolism of bacteria
operates close to the Pareto-optimal surface of a three-dimensional space
defined by competing objectives and demonstrated the validity of their
claims for various environmental perturbations [1]. Albeit multi-objective
approaches focused on the bio-engineering objectives have been proposed (
Chaper 3), none tackles the multi-objective nature of the cellular objectives.
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4.1 Introduction
Assumptions regarding the cellular objectives of an organism when sub-
jected to distinct conditions (environmental, genetic, etc.) are still the
object of active discussion. The most common approach is to consider the
cell to be in a pseudo steady-state and, since the solution space for the
metabolic fluxes of the cell is usually very large, constraint based optimiza-
tion approaches are often applied for simulating metabolic fluxes. Given
this assumption, it is therefore plausible to predict cellular behaviour by
solving optimization problems, as long as biologically realistic objective
functions are put forward. Several methods have been developed to solve
these problems. Among these, Flux Balance Analysis (FBA) [2] is a widely
used phenotype prediction tool that uses a linear programming (LP) for-
mulation often for the maximization of growth (synthesis of biomass con-
stituents) as the objective function, considering the biological assumption
that organisms tend to maximize their growth [3].
However, to predict the cellular behaviour of mutant organisms, such
assumption is not widely accepted and, for that specific purpose, other
methods have been proposed such as Minimization of Metabolic Adjust-
ment (MOMA) [4] and Regulatory On/Off Minimization of metabolic flux
changes (ROOM) [5]. MOMA’s formulation is based on Quadratic Pro-
gramming (QP) and the objective function is the minimization of flux vari-
ations relatively to the wild-type.
As for ROOM, the principle is similar, only the formulation is based
on Mixed Integer-Linear Programming (MILP) and the objective function
is the minimization of the number of perturbed fluxes from the mutant
relatively to the wild-type. The hypothesis underlying both MOMA and
ROOM is that fluxes in a perturbed cell (e.g. a mutant) will be redistributed
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in order to be as similar as possible to the wild-type [6]. These methods
are described with greater detail in Chapter 2.
In this work, we focused on variations of two of the most widely used phe-
notype prediction methods, the parsimonious enzyme usage FBA (pFBA)
(a variation of FBA that minimizes the overall sum of enzyme-associated
fluxes [7]) and LMOMA (a linear implementation of MOMA [8]). We an-
alyze the influence of the simulation methods on the results of strain opti-
mization metaheuristic algorithms and suggest a multi-objective approach
capable of finding designs compliant with the cellular objectives assumed
by the various phenotype prediction methods.
We have confirmed that the results of strain optimization meta-heuristics
are highly dependent on the phenotype prediction methods, and specifi-
cally, the use of FBA/pFBA leads to sub-optimal results in more challeng-
ing tasks. The proposed multi-objective approach reveals itself as a valid
method to overcome these limitations, being able to reach solutions that
are robust, both taking into account the phenotype simulation method and
the minimum granted compound production.
4.2 Effects of phenotype prediction
methods over strain optimization
4.2.1 Methods
Using a recent model of Escherichia coli K12 (iAF1260) [9], and as a way of
avoiding being mislead by any particular set of experimental conditions, the
experiments were setup for multiple environmental conditions (aerobiose,
anaerobiose), multiple carbon sources (glucose, xylose and glycerol) and
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multiple target products (lactate, succinate, pyruvate, phenilalanine and
glycerol).
Initially, the two metaheuristics described in Chapter 3 (EAs and SAs)
were executed using both pFBA and LMOMA as the phenotype prediction
method, using the BPCY objective function. For each, the execution was
halted after 50000 function evaluations and the process was repeated 30
times. The remaining configuration parameters for these algorithms are
the same that were used in the previous chapter. For analysis purposes,
the resulting solution sets for the EA and SA algorithms were merged for
each set of conditions. However, the convergence analysis is done separately
(algorithm-dependent).
4.2.2 Results
A summary of the number of solutions generated by each of the algorithms
in each conditions is presented in Table 4.1. In this table, only solutions
that are BPCY-valid are considered, i.e. where BPCY ≥ 1 × 10−5. Note
that this was a criterion used to take into account solutions where both the
biomass and target compound fluxes are larger than zero.
In an initial analysis of this table, the larger number of solutions reach-
able when LMOMA is the used phenotype prediction method is easily ob-
servable. This seems to imply that the space of BPCY-valid solutions is
larger when LMOMA is used in the simulation, leading the algorithms to
more rapidly finding interesting solutions. This fact is one of the insights
that lead to the development of our multiobjective approach, as will be
later discussed in more detail.
While the conclusions are extensible for all the case studies, in the fol-
lowing the results and discussion will be pointed only for the aerobic produc-
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Table 4.1: Size of the merged solution sets (EAs and SAs) for the various case studies.
Target products: Lac. - lactate, Suc. - succinate, Pyr. - pyruvate, Phe. - phenylalanine,
Gly. - glycerol
Condition Substrate Method
Target Product
Lac. Suc. Pyr. Phe. Gly.
Aerobic
Glucose
pFBA 292 143 20 2 1
LMOMA 661 1187 1317 489 433
Glycerol
pFBA 343 354 309 12 –
LMOMA 506 730 839 526 –
Xylose
pFBA 350 211 69 0 3
LMOMA 757 654 407 351 350
Anaerobic
Glucose
pFBA 15 9 95 73 0
LMOMA 1186 123 597 259 258
Xylose
pFBA 15 7 151 0 0
LMOMA 587 133 946 449 314
tion of lactate and succinate using glucose as a carbon source. The results
for the remaining case studies are available in supplementary material in
http://darwin.di.uminho.pt/pmaia/phdthesis.
In order to understand how different phenotype prediction methods af-
fects the solutions reached by the algorithms, the convergences of the EA
and SA, when using pFBA and LMOMA were analyzed separately. Figure
4.1 depicts the convergences in the Lactate and Succinate case studies.
In a first observation of the convergence plots, a smoother convergence
when the LMOMA phenotype prediction method is being used becomes
evident. When pFBA is the selected method, the convergence evolves in a
stepped pattern, with no observable change in fitness for several evaluation
functions and larger fitness jumps in some steps. The LMOMA pattern is
a smoother one, represented by slight but constant increases in fitness until
convergence is attained. In the easier case study, lactate, these differences
are not so easily observable, while in the more difficult one, succinate, this
trend becomes evident. These trends are extensible to the additional case
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Figure 4.1: Convergence plots for the EA and SA algorithms applied to the aerobic
production of lactate and succinate from glucose. The solid lines indicates the
means of 30 runs, while the color-shaded areas indicate the standard deviation.
The dashed lines represent the maximum value for each algorithm and problem.
studies (in supplementary material) where, in some cases, these patterns
are even more declared.
To evaluate the effect that these differences had in the phenotype (flux
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values) of the solutions reached by the algorithms with each of the phe-
notype prediction methods, an analysis on the flux distribution of such
solutions was devised. A wild-type flux distribution was predicted using
pFBA and taken as the reference flux distribution. The distribution of flux
distances from the mutant phenotypes to this reference was then computed
(Figure 4.2). To meet this end, the Jaccard distance for asymmetric binary
attributes (dJ) was employed:
dJ =
M01 +M10
M01 +M10 +M11
(4.1)
where M01 represents the total number of fluxes active in the mutant, but
inactive in the wild-type; M10 is the total number of fluxes active in the
wild-type but not in the mutant; and, M11 is the number of fluxes that
are active in both the mutant and the wild type flux distributions. This
metric only considers the flux differences as a binary array (on or off), thus
ignoring the effective flux levels.
Every solution generated by the EA and SA, while using LMOMA
(LMOMA-generated) was re-simulated using pFBA (top histogram in each
chart) while every solution generated using pFBA (pFBA-generated) was
re-simulated using LMOMA (bottom histogram in each chart). By visually
inspecting the histograms, some observations are possible:
1. Overall, the solutions simulated by LMOMA are usually farther from
the wild-type than the ones simulated by pFBA;
2. When re-simulated with pFBA, the LMOMA-generated solutions, are
generally closer to the wild-type than the pFBA ones;
3. When re-simulated with LMOMA, the pFBA-generated solutions are
generally much farther from the wild-type than the LMOMA ones.
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Figure 4.2: Distribution of the Jaccard distances from the solutions flux distribu-
tions to the wild-type flux distributions for the aerobic production of lactate (a)
and succinate (b) from glucose. Red bins and blue bins represent solutions gener-
ated by LMOMA and pFBA, respectively. Solutions were re-simulated with pFBA
(top in each plot) and LMOMA (bottom in each plot).
Some of them even have a dJ > 0.5.
These facts can be dissected and analyzed in more detail. The formula-
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tion of the pFBA procedure helps explaining the observation 1 given that,
for a given flux space that maximizes biomass, it will return the flux dis-
tribution that minimizes the overall sum of fluxes. On the other hand, the
fact that LMOMA solutions are closer to the wild-type than pFBA ones,
even when simulated with pFBA (observation 2), can be attributed to the
fact that the LMOMA objective function tries to minimize the distance be-
tween the wild-type and the mutant flux distributions (i.e., there is a bias
in the LMOMA optimization towards this objective). This is important,
because we assume that solutions that are closer to the wild-type are more
likely to work in reality [4]. This is observable for simulations with pFBA
and LMOMA. On the other hand, the solutions simulated with pFBA are
generally closer to the wild-type, which can be attributed to the pFBA
objective function that minimizes the overall sum of fluxes. This means
that pFBA simulations are probably closer to ROOM than LMOMA. Fi-
nally, in observation 3, the pFBA-generated solutions are clearly modifying
a higher number of fluxes when they are simulated with LMOMA. This can
be explained by the fact that the pFBA procedure does not have any bias
towards flux distributions that are closer to the wild-type.
Another question that quickly arises is how many solutions, generated
by each of the methods, are actually valid when simulated with the other.
Venn-like diagrams are presented in Figure 4.3 to provide a first answer to
this question.
It is easily observable that a large number of solutions (about half) are
not BPCY-valid for both methods. From these, the majority are BPCY-
valid for LMOMA only. This trend can also be observed in the other case
studies available in the supplementary material, although with some varia-
tions. This confirms that the phenotype prediction method is a determining
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Figure 4.3: Venn-like diagrams for checking the inter-method validity of the so-
lutions. From left to right, solutions that are BPCY-valid for: only pFBA, both
pFBA and LMOMA, and only LMOMA.
factor not only on the performance of the strain optimization algorithms,
but also in the sets of solutions they yield. If we assume that the likelihood
of these solutions working in reality increases if they are valid using different
phenotype prediction methods methods, then most of the solutions found
are not robust.
While it is also clear that, in these case studies, there is a good set of
solutions that are BPCY-valid for both methods, the quality of these solu-
tions is not addressed, since this analysis includes solutions whose BPCY
values are close to zero (≥ 1× 10−5).
To better understand how the fitnesses vary as a function of the phe-
notype prediction methods, Figures 4.4 and 4.5 are put forward, where the
BPCY-values are taken into account. In Figure 4.4, solutions generated by
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the strain optimization algorithms when one of the phenotype prediction
methods was used were re-simulated with the other, their BPCY values
were calculated for both cases and represented in the form of boxplots.
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Figure 4.4: BPCY (mmol product . mmol substrate−1 . h−1) boxplots for the Lac-
tate (a) and Succinate (b) case studies. Solutions generated with pFBA (blue,right)
and LMOMA (red,left) are re-simulated using both methods (x-axis).
From the boxplots it is clear that the distribution of the BPCY values of
the solutions generated when using one of the phenotype prediction methods
changes dramatically when using the other. Remarkably, in the succinate
case study, the average BPCY of the LMOMA-generated solutions when
simulated with pFBA is superior to the average of the pFBA-generated
solutions.
This fact is further supported by the scatter plots presented in Figure
4.5, which allow the visualization of the BPCY obtained using the two
different methods for individual solutions.
In these plots, particular attention should be paid to the LMOMA so-
lutions in the top right region of the plots. In the perspective of this work,
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Figure 4.5: Scatter plots showing BPCY
(mmol product . mmol substrate−1 . h−1) values obtained by LMOMA(red)
and pFBA(blue) generated solutions when simulated using pFBA (x-axis) and
LMOMA (y-axis) for the lactate (a) and succinate (b) case studies.
these will be the desired solutions since they provide good results using
both prediction methods, being considered more reliable.
Albeit being curious, this can be partially attributed to the larger/less
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constrained LMOMA solution space. That is, in cases where few valid FBA
solutions exist, and there is the necessity for a specific (and restricted) com-
bination of knockouts to guarantee the production of a desired compound,
that specific combination might be hard to reach using FBA, thus rendering
the optimization process close to a random sampling while no valid solution
is found. Alternatively, LMOMA solutions can spread the flux by multiple
reactions reaching a multitude of valid solutions from the early stages of
the optimization, i.e, with few knockouts (this effect can be observed in
the convergence plots). Some of these solutions or areas of the LMOMA
solution space are BPCY-valid for FBA as well, as shown by Figures 4.4
and 4.5. This supports the rationale that LMOMA-based optimization can
be used to guide the FBA-based optimization, which was used as one of
the pivotal reasonings behind the development of the tandem optimization
approach detailed in the next section.
4.3 Robust strain optimization by means of
tandem phenotype prediction
4.3.1 Methods
Leveraging on the developments presented in Chapter 3, a multi-objective
mechanism, capable of searching for genetic designs compliant with two or
more phenotype prediction methods, was devised. The SPEA2 algorithm
is used with the same configuration as the one used in the previous chapter
(details of the algorithm are available in Section 5.4). The main differ-
ence concerns the evaluation of the solutions. In this case, each solution is
decoded as before and simulated independently using the selected pheno-
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type prediction methods, which in the experiments will be two: pFBA and
LMOMA. These originate two distinct flux distributions which will be eval-
uated using BPCY. These two values, BPCY-pFBA and BPCY-LMOMA,
make the two objective functions used by SPEA2.
4.3.2 Results
We applied our approach to all previously presented case studies and com-
pared the results. However, as before, the analysis will be focused on the
aerobic production of succinate and lactate using glucose as the carbon
source, while full results are provided in supplementary material. Table
4.2 summarizes the number of solutions found by our method in every case
study.
Table 4.2: Size of the solution sets for the various case studies, using the tandem opti-
mization approach.
Target Product
Lactate Succinate Pyruvate Phenylalanine Glycerol
Aerobic
Glucose 1184 709 671 1393 610
Glycerol 741 537 494 459 –
Xylose 568 745 789 256 60
Anaerobic
Glucose 981 1376 669 347 49
Xylose 469 1646 594 234 62
With a quick inspection of Table 4.2, the generally larger number of
BPCY-valid solutions found across the various case studies when compared
with Table 4.1 is easily perceptible.
Figure 4.6 represents the Jaccard distance of the mutant flux distri-
butions (solutions found by the tandem approach) to the wild-type flux
distribution. From the histograms, it is possible to conclude that, while the
average distance of the LMOMA-based flux distributions when simulated
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with both pFBA and LMOMA has not decreased significantly in compari-
son with the EA/SA approaches, the outliers found in the pFBA-based flux
distributions when simulated with LMOMA are not present anymore.
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Figure 4.6: Distribution of the Jaccard distances from the solutions flux distribu-
tions to the wild-type flux distributions for the aerobic production of lactate (a)
and succinate (b) from glucose. All the solution were re-simulated with pFBA (top
in each plot) and LMOMA (bottom in each plot).
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This observation suggests that the current solutions are closer to each
other in terms of flux distributions. Notwithstanding, as stated in the pre-
vious section, if we assume that the likelihood of the solutions working in
reality increases, if they are valid for different phenotype prediction meth-
ods, no conclusions can be derived about the inter-method validity of these
solutions. To access the validity in both pFBA and LMOMA phenotype
prediction methods, Figure 4.7 is introduced. The results presented in the
Venn-like diagrams are self-explanatory, with all solutions but 2 in the suc-
cinate case study and 1 in the lactate case study being BPCY-valid for both
methods. This result is extremely positive by itself, however, the precise
performance of these solutions remains to be evaluated.
(a) Lactate
BOTH LMOMA
(1182) (2)
0 300 600 900 1200
Number of solutions
PFBA
BOTH
LMOMA
(b) Succinate
BOTH LMOMA
(708) (1)
0 200 400 600
Number of solutions
PFBA
BOTH
LMOMA
Figure 4.7: Venn-like diagrams for checking the inter-method validity of the so-
lutions. From left to right, solutions that are BPCY-valid for: only pFBA, both
pFBA and LMOMA, and only LMOMA.
The hypothesis raised in the previous section, that the LMOMA-based
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optimization could be used to guide the pFBA-based optimization, is now
revisited here. The corresponding boxplots were generated and are pre-
sented in Figure 4.8.
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Figure 4.8: BPCY Boxplots for the Lactate (a) and Succinate (b) case studies
obtained by the tandem approach. Solutions are re-simulated with both methods
(x-axis).
By analyzing the boxplots it is now evident that the results have im-
proved greatly in comparison with the previous approach. In the Lactate
case study, while in the former approach the pFBA-generated solutions
were generally not valid with LMOMA and the LMOMA-generated solu-
tions were not valid with pFBA, here, the solutions are not only valid, but
the average of their BPCY values is better, in particular for the pFBA
method.
Even more interesting are the results of the Succinate case study. In the
previous section, we pointed out the curious results found for this example,
where the LMOMA-generated solutions achieved better BPCY values when
simulated with pFBA than the pFBA-generated solutions themselves. It is
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clear that the tandem approach is able to find still better solutions that are
valid with pFBA, than in the previous approach, with an average BPCY
of 0.6 mmol product . mmol substrate−1 . h−1. This improvement in the
results can also be witnessed in the scatter plots presented in Figure 4.9
where a large portion of the solutions are located on the top-right region of
the plots.
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Figure 4.9: Scatter plots showing BPCY values obtained by the tandem approach
generated solutions when simulated using pFBA (x-axis) and LMOMA (y-axis)
for the lactate (a) and succinate (b) case studies.
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4.3.3 LMOMA solutions act as a chaperone for the
identification of pFBA-valid solutions in
tandem pFBA/LMOMA optimization
One of our claims is that, in very constrained FBA solution spaces where
few BPCY-valid solutions exist, i.e., where to reach solutions than can
couple biomass growth and target overproduction a large number of specific
deletions is required, the LMOMA-based optimization process can act as
chaperone for the FBA-based optimization. To help illustrate this process,
Figure 4.10 is put forward.
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Figure 4.10: Illustration of LMOMA-pFBA tandem optimization. Solution spaces with
few knockouts contain no valid pFBA solutions while some LMOMA solutions can be
found. In the much larger, many-knockouts, solution space, pFBA, LMOMA and pF-
BA/LMOMA solutions are found.
The early stage LMOMA solutions allow the algorithm to initialize con-
vergence towards interesting regions of the solution space, by using solely
LMOMA solutions’ fitnesses. For higher numbers of deletions, despite be-
ing scarce, valid pFBA solutions exist. However, the probability of a valid
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combination of deletions being found by an evolutionary heuristic using
only pFBA as the phenotype prediction method is low. When (and if)
the LMOMA and pFBA feasible solution spaces intersect, the tandem opti-
mization approach starts to attribute more value to solutions that are valid
for both methods. This is a natural outcome of the dominance property of
the underlying MO approach.
To analyze the validity of these claims, we selected the top pFBA
/ LMOMA solution (the solution that attained the best mean BPCY-
pFBA/BPCY-LMOMA) from the succinate case study, and generated all
its sub-solutions.
The selected solution (sΦ) comprised the following 19 gene deletions:
sΦ = ∆prpE, ∆mhpF, ∆sucD, ∆pflA, ∆ndh, ∆dhaK, ∆adhE, ∆ldhA,
∆pntA, ∆edd, ∆gnd, ∆dld, ∆maeB, ∆gcvT, ∆aldB, ∆tnaA, ∆gldA, ∆pflD,
∆idnO. For each size smaller than the one of sΦ,all possible combinations
of sub-sets of sΦ were tested, and the best BPCY and percentage of valid
solutions for both pFBA and LMOMA were compiled (Table 4.3). The
total number of combinations amounted to over 500.000 and the respective
phenotype simulations (pFBA/LMOMA) to over 1 million.
While we only accounted for 19 possible genes, the total number of genes
available for the algorithms to combine is, in this case study, 240. The
possible number of combinations of these 240 genes in order to generate 10-
deletion solutions is 1.44×1017. If the pFBA-feasible sub-solution space of
these solutions is proportional to that of this solution, it will be very hard
for any heuristic algorithm to find a valid combination. It is also worth
mentioning that deterministic methods, such as OptKnock [10], do not to
scale to these sizes.
By analyzing Table 4.3, it is possible to observe that until reaching
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Table 4.3: Analysis of the sub-solution space of solution sΦ. For each size of sub-set of
sΦ, the best BPCY and percentage of valid solutions, for both pFBA and LMOMA are
presented. BPCY units are mmol product . mmol substrate−1 . h−1
Deletions # Solutions
Best BPCY Valid Solutions
pFBA LMOMA pFBA LMOMA
1 19 0.00000 0.00001 0.000% 5.263%
2 171 0.00000 0.03992 0.000% 10.526%
3 969 0.00000 0.19762 0.000% 15.996%
4 3876 0.00000 0.32428 0.000% 21.827%
5 11628 0.00000 0.35743 0.000% 28.113%
6 27132 0.00058 0.41588 0.004% 34.896%
7 50388 0.41190 0.41774 0.026% 42.153%
8 75582 0.45917 0.46551 0.106% 49.780%
9 92378 0.47226 0.49940 0.336% 57.587%
10 92378 0.70233 0.51212 0.913% 65.310%
11 75582 0.70283 0.52409 2.231% 72.652%
12 50388 0.71425 0.53329 5.001% 79.342%
13 27132 0.71468 0.56377 10.353% 85.176%
14 11628 0.71468 0.59254 19.788% 90.033%
15 3876 0.71491 0.59458 34.778% 93.885%
16 969 0.71491 0.59984 55.728% 96.801%
17 171 0.71491 0.60317 80.117% 98.830%
18 19 0.71491 0.60502 100.000% 100.000%
19 1 0.71348 0.60504 100.000% 100.000%
6 gene deletions (gray region), no sub-solutions attained BPCY-valid flux
distributions for pFBA and, before 10 gene deletions (light gray region),
the number of valid sub-combinations was bellow 1%. Alternatively, the
LMOMA solution sub-space allowed for valid combinations with as low as
1 deletion (1 deletion out of 19 predicted both biomass and succinate). The
percentage of valid combinations for LMOMA increases steadily with the
number of gene deletions. This allows the algorithm to use these solutions to
navigate the solution space, ranking them on top of the current population
and allowing them to recombine more often in order to generate offspring.
When a valid pFBA/LMOMA solution is found (a point in the inter-
section of the pFBA and LMOMA feasible solution spaces), the dominance
property of the algorithm attributes a higher ranking to this solution which,
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in turn, increases its chance to generate derivative solutions. Solutions that
are both pFBA and LMOMA valid are always given more reproductive pri-
ority, which introduces a bias for the algorithm to explore that region of
the flux cone.
To give better support to this analysis, we argue that the smallest pFBA-
valid solution found: (sψ = ∆mhpF, ∆pflA, ∆adhE, ∆ldhA, ∆dld, ∆pflD)
is either an increment of a valid LMOMA 5-deletion solution or a combi-
nation of two LMOMA valid solutions. To investigate this, we scanned all
the sub-solutions with 5 deletions or less, and found out that:
• there are two LMOMA valid 5-deletion solutions that could have been
incremented with an extra deletion to generate sψ, namely:
1. ∆mhpF, ∆pflA, ∆ldhA, ∆dld, ∆pflD;
2. ∆pflA, ∆adhE, ∆ldhA, ∆dld, ∆pflD
• there are 1746 valid LMOMA sub-solutions (sizes 1 to 5) that could
be combined to generate sψ;
Also, there are 36 LMOMA valid 6-deletion solutions that could have
been mutated to generate sψ, by replacing one of their elements.
Naturally, a more thorough analysis of these solutions and their sub-
spaces is required to give a stronger statistical significance to this claim.
Nonetheless, the results and preliminary analysis, strongly support our
claim.
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4.3.4 Tandem optimization yields robust strain
optimization designs
In this context, our interpretation of robustness is two-fold. First, we intro-
duce a new concept of robustness in which solutions that are predicted by
more than one phenotype prediction method are more robust, since they
comply with more than one assumption regarding the behavior of the or-
ganism when subjected to perturbations. While we will not provide any
further tests supporting this claim, this robustness is a natural consequence
of the objective functions of our tandem approach, which are sufficiently
detailed in our previous analyses.
Secondly, we argue that the tandem optimization process is able to
attain solutions that are also robust in the LP (FBA) solution cone (FBA-
robustness). The problems associated with competing pathways not being
accounted for by strain optimization algorithms were first brought to light
by Tepper and Schlomi in [11] where they introduced the concept of robust
solutions.
The FBA-robustness is tested in a 2-step approach, first a regular FBA
phenotype prediction is performed, maximizing the biomass (biostep1), while
subjected to the genetic and environmental conditions of the solutions.
Next, FBA is performed with the objective of minimizing the production of
the target compound, but an extra constraint - biostep2 ≥ biostep1 ∗ (1− α)
where α = 0.00001- is added to the problem. If FBA is still able to predict
the production of the target compound in these conditions, we consider the
solution to be FBA-robust.
To analyze the validity of this claim, we observed the FBA-robustness
of the solutions reached by the tandem algorithm in every case study. The
results of this analysis are summarized in Table 4.4.
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Table 4.4: Percentage of FBA-robust solutions in all the case studies.
Target Product
Lactate Succinate Pyruvate Phenylalanine Glycerol
Aerobic
Glucose 75.9% 99.9% 100% 68.7% 35.5%
Glycerol 86.0% 100% 100% 72.6%
Xylose 75.4% 93.2% 100% 0.0% 8.3%
Anaerobic
Glucose 99.5% 100% 96.1% 79.8% 2.0%
Xylose 99.2% 100% 99.8% 0.0% 0.0%
A quick analysis of the table allows us to conclude that, for the majority
of the case studies, most of the solutions found by the tandem algorithm are
FBA-robust. The percentage of FBA-robust solutions found by our method
is in the same range of the previous methods (consult supplementary mate-
rial), however, our method is able to find a much larger number of solutions.
Thus, as a consequence, a higher number of FBA-robust solutions is made
available to the researchers. For the most difficult case studies, such as the
anerobic production of phenylalanine and glycerol from xylose, few or no
robust solutions could be found, suggesting that either they do not exist
(for up to 20 gene deletions) or they are extremely scarce and difficult to
find.
4.4 Conclusions
In this work, a new tandem optimization approach capable of finding robust
strain designs compliant with multiple phenotype prediction methods is
proposed. Several advantages emerge from using this tandem approach.
First, the algorithm helps uncovering pFBA solutions that would otherwise
be difficult to find by traditional approaches. Secondly, the majority of
these solutions are both FBA-robust and multi-phenotype robust.
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Arguably, a valid alternative would be to ignore FBA/pFBA as a phe-
notype prediction method for perturbed/mutant organisms and use MO-
MA/LMOMA. However, LMOMA designs suffer from some limitations.
Given that the objective function in MOMA/LMOMA is to minimize the
distance to the wild-type flux distribution and since it is not bound to the
maximization of biomass constraint, MOMA can artificially activate/deac-
tivate a large number of reactions in order to reach this minimum value.
This results in flux distributions with a large number of minimally activated
fluxes, which is unlikely to be biologically sound. Furthermore, because of
this, the analysis of the flux distribution of MOMA/LMOMA solutions is a
challenging task, whereas analyzing pFBA flux distributions is an amenable
one. The solutions attained by our tandem algorithm provide the advan-
tages of both approaches with none of the shortcomings.
It is also worth mentioning that the implementation of a similar ap-
proach via a bi-level design algorithm, such as RobustKnock [11] is not a
trivial (if at all possible) task. Moreover, the unique perspective granted
by the MO nature of the tandem algorithm would not be possible.
Further work includes testing alternative phenotype prediction methods
such as ROOM and MiMBl, which are already supported by the imple-
mented framework (see Chapter 5).
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chapter 5
DEVELOPMENT OF SOFTWARE TOOLS
The need to develop the software tools required for the optimizations and
analysis discussed in both Chapters 3 and 4, and the conscience acquired
in the previous chapters that no single method is optimal for all partic-
ular strain optimization problem, led us to design and implement a well
structured software framework that could be made available to the ME
community.
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5.1 Introduction
The developed framework is structured into multiple layers and provides
different levels of user experience, thus allowing both experienced program-
mers and expert researchers to configure and fine tune strain optimization
strategies tailored to their own needs. This is accomplished by a modular
software design, allowing both a graphical user interface (GUI) which en-
capsulates powerful tools for users without programming experience, and
a versatile application programming interface (API) for developers that
are able to use the provided libraries or contribute to their extension with
new methods. Note that some of these libraries are a joint effort of several
members of the institute where this thesis was developed. The libraries and
packages exclusively developed or significantly extended during this work
will be specially detailed. A summary of the main contributions regarding
software development are presented in Table 5.1.
5.2 Application Programming Interface
Layer
The API and GUI constitute the two top level software layers and their
structure is represented in Figure 5.1. The API layer comprises 5 distinct
libraries: Metabolic3, BioComponents, Solvers, Jecoli3 and MetabolicAnal-
ysis. The GUI layer is provided by the OptFlux3 Metabolic Engineering
Workbench [1] via the optimization plug-in and will be discussed in the
next section.
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Table 5.1: Summary of the main contributions regarding software development during
this work.
Library Main contributions
Metabolic3 The configuration package has been fully developed during this work.
A completely new, more powerful version of the commandline tools has
been implemented to support the new configuration package.
The simplification package has been fully updated to support the new
persistent mode developed for the solvers library.
The essentiality/targets package has been fully redesigned. Only 2 of
the 9 currently available methods were developed developed prior to
this work. A control center was also developed to centralize and offer
API access to these procedures.
All the phenotype prediction methods have been re-formulated and
re-implemented from scratch to support the new persistent mode de-
veloped for the solvers library.
A new version of the strain optimization package was developed during
this work. New methods and new strategies were implemented on top
of a completely new optimization framework.”
Solvers The solvers library has been extended to support a persistent mode.
This persistent mode is implemented as a wrapper to the CPLEX op-
timizer that allows keeping the inner model of the optimizer constant,
changing only specific variables, constraints or objective functions as
needed. This extension has allowed a 10 to 20 fold speed-up relatively
to the previous version.”
Jecoli3 ”The main additions to the Jecoli library were made in the evolution-
ary multi-objective domain. Two new MOEAs (SPEA2 and NSGA-II)
were added to list of available methods. Moreover, an archive man-
ager, common to all the algorithms has also been developed. Smaller
improvements were made throughout this thesis.
MetabolicAnalysis The MetabolicAnalysis package was fully developed during this work.
OptFlux3 A new Strain Optimization plug-in was fully developed during this
work.
5.2.1 Metabolic3
The Metabolic3 library is the core of the framework. It is responsible for
the interaction with the models in their various formats, formulation of all
the previously discussed phenotype prediction methods, the computation
of the essential information and the strain optimization procedures. The
Metabolic3 library includes an API that allows programmers to take ad-
vantage of all the provided facilities. The library is segmented in several
packages, from which the most relevant ones are detailed next.
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Metabolic3
Configuration
CommandLine Tools
Model
Simplification
Essentiality/Targets
MetabolicAnalysis
BioComponents
Phenotype Prediction
Strain Optimization
Solvers
Jecoli3
OptFlux3
GUI
API
Figure 5.1: Overview of the developed libraries. The GUI layer is provided by the
OptFlux workbench whereas the API layer is composed by a total of 5 libraries:
Metabolic3, BioComponents, MetabolicAnalysis, Solvers and Jecoli3.
Model
The Model package provides data structures to support all the information
pertinent to stoichiometric metabolic models. A stoichiometric model is
composed by the list of reactions and their constraints (flux capacity, re-
versibility), the list of metabolites and the stoichiometric coefficients in a
matrix form. If available, the genes and respective gene-protein-reaction
(GPRs) rules, as well as the pathways, are also integrated in the model in-
formation. The input/output facilities are provided via the BioComponents
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library as displayed in Figure 5.2.
BioComponentsMetabolic3
Configuration
CommandLine Tools
Model
Simplification
removeEquivalentReactions()
removeBlockedReactions()
ModelSimplification 
ControlCenter
Components
StoichiometricModel
Reactions/Metabolites/Genes
GPR rules/Pathways
ReactionConstraints
EnvironmentalConditions
GeneticConditions
Solvers
Phenotype Prediction
Strain Optimization
simplifyRKSolution()
simplifyGKSolution()
simplifyOptimizationResult()
SolutionSimplification
Essentiality/Targets
identifyCritical()
identifyNonGeneAssociated()
identifyDrains()
identifyTransports()
identifyZeros()
identifyEquivalences()
identifyPathwayRelated()
identifyHighCarbonRelated()
identifyExperimental()
OptimizationTargets 
ControlCenter
MetabolicAnalysis
Jecoli3
Components
Container
Reaction
Metabolite
CrossReferences
Stoichiometry
Gene/GeneRule
Compartment
IO
SBML Reader / Writer
Metatool Reader / Writer
BioOpt Reader / Writer
FlatFiles Reader / Writer
CSV Reader / Writer
Database Reader / Writer
Figure 5.2: The API layer highlighting the Model, Simplification and Essentiality
/ Targets packages, as well as the interaction with the BioComponents library.
Simplification
The Simplification package includes procedures for both model reduction
and solution simplification. Model simplification is a common step in the
workflow of computational strain optimization procedures, allowing savings
of memory and improved performance. Both model reduction procedures
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are detailed in [2]. The solution simplification procedures allow the removal
of modifications that are not contributing to a set of specified objective
functions.
Essentiality/Targets
The Essentiality/Targets package provides methods to identify critical in-
formation that should be withheld from the list of optimization targets.
Most of these strategies were implemented according to the steps reported
by Feist and co-workers [3]. These include:
• Essential and nearly essential reactions - all the reactions that,
when no flux is allowed to be carried over them, render the biomass
growth below a given percentage of the wild-type;
• Non gene-associated reactions - reactions (metabolic) that either
occur spontaneously or, due to deficient functional annotation, do not
possess any gene association;
• Drains - identify the sinks and sources, pseudo-reactions added to
allow interaction of the model with external medium;
• Transports - identify membrane transport protein associated reac-
tions;
• Blocked or zero flux reactions - reactions that, for the current
environmental conditions (reaction constraints) are blocked, thus not
allowing flux to be carried through them;
• Co-sets - equivalent reactions - reactions that are topologically
equivalent (e.g. linear pathways) are grouped and only one of them
is considered in the analysis;
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• Reactions in selected pathways - reactions occurring exclusively
in user-defined pathways (e.g. peripherical) can be marked as non-
targets;
• Reactions acting on high-carbon metabolites - all the reactions
that act on high-carbon containing molecules will be removed from the
targets list. The number of carbons is defined by the user (the default
value is 7 carbons). This strategy requires the definition of a list of
exceptions, i.e., a list of metabolites (cofactors and other exceptions)
that, despite having high-carbon content, must not be included in this
analysis;
• Reactions related to experimentally validated lethal genes
- By using databases of essential genes, the associated reactions are
calculated and marked as non-targets. Two databases were included:
– Keio collection [4] - a list of experimentally validated single-
gene knockouts for E. coli ;
– OGEE - [5] - an online gene essentiality database for multiple
organisms.
Phenotype Prediction
The Phenotype Prediction package is responsible for the formulation of all
the phenotype prediction problems, offering different methods for their so-
lution. This package includes classes that allow the specification of a phe-
notype prediction method and its use to simulate the behaviour of both
wild-type and mutant strains. It allows the prediction of the flux distri-
butions of wild-type strains using the environmental conditions defined in
the Model package. Moreover, it allows the prediction of flux distributions
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for mutant strains, using both the environmental and genetic conditions
defined in the model layer. It currently includes implementations of the fol-
lowing formulations: FBA, pFBA, MOMA LMOMA, ROOM and MiMBl
as well as FVA. All of these methods were previously described in Chapter
2.
Each formulation is the realization of an abstract problem class provided
by the Solvers library. In Figure 5.3, this interaction with the Solvers li-
brary (described in Section 5.2.2) is exemplified. Finally, the SteadyState-
SimulationControlCenter API class serves as a control center that ag-
gregates and provides easy access to all the features and functions of the
package.
Strain Optimization
The Strain Optimization package is the core subject of this work and the
functionalities developed in this context present one of thesis major contri-
butions. This layer allows for the definition, tuning and solving of the strain
optimization problem that better suits the user requests. In the context of
strain optimization, a problem can be defined as: for a given optimiza-
tion strategy, find the optimal set of modifications that optimize a set of
objective functions.
The optimization strategies that are allowed in this framework include
gene knockouts (GK), reaction knockouts (RK), gene over/under expression
(GOU) and reaction over/under expression (ROU). A reaction knockout is
accomplished by blocking that reactions’ flux by setting its upper and lower
constraints to zero. Since the models are reaction-oriented (i.e. the genes
are not directly represent in the metabolic network), a gene knockout is
implemented by analyzing that gene’s rule (the GPR) and blocking the flux
Algorithms and Tools for in silico Design of Cell Factories
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Figure 5.3: The API layer highlighting the Phenotype Prediction and Strain Opti-
mization packages of the Metabolic3 library and their interaction with the Solvers
and Jecoli3 libraries.
of all the reactions that are exclusively promoted by that gene. Alterna-
tively, an over/under expression is accomplished by forcing the flux through
a given reaction to be increased or decreased relatively to the original value
in a reference flux distribution (typically the wild-type flux distribution).
More details about the over/under expression approach can be explored
in [6].
The objective functions are the most important user input, in the sense
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that they identify what are the optimization targets/objectives. An exam-
ple is the maximization of the flux of a given reaction (over-production of
a compound of interest). Several objective functions are readily available,
including:
• Biomass-Product Coupled Yield (BPCY) [7]: This objective
function couples (via multiplication) the biomass flux (B) with the
selected product flux (P ) relative to the substrate (S) consumption:
BPCY (solution) = B×P
S
;
• Carbon Yield (CYIELD): Computes the yield of the desired prod-
uct flux (P ) relative to the substrate consumption flux (SS) normal-
ized to the carbon content of both compounds (CP and CS, respec-
tively): CY IELD(solution) = P.CP
S.CS
.. This objective function requires
that the formulas of the compounds are available;
• Product Yield with minimum biomass (YIELD): Computes the
yield of the desired product flux (P) relative to the substrate consump-
tion (S) ensuring that a minimum percentage of biomass (relative to
the wild-type) is produced: Y IELD(solution) = P
S
, Bmut ≥ αBwt,
where Bmut is the biomass of the mutant, Bwt is the biomass of the
wild-type strain and α is a user defined percentage;
• Flux value: Maximizes or minimizes the value of a specified reaction
flux;
• Number of knockouts (or over/under expressions): Minimize
the number of modifications performed to the mutant strain;
• Sum of flux measures: Maximize or minimize the sum of all the
fluxes in the flux distribution (metabolic activity).
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The package supports the selection of multiple objective functions to be
optimized in parallel. In fact, even if a single objective (SO) algorithm is
selected and multiple objective functions are defined, the framework is still
able to follow the multi-objective principles. This feature is accomplished
through the use of aggregation functions (that can be specified by the user)
and the work of an archive manager which manages the solutions reached
by the algorithms according to user-defined criteria (refer to Section 5.2.3
for more details).
The optimization package also allows the selection of environmental con-
ditions to use in the optimization problems, as well as taking into account
the essentiality information and targets to be considered by the optimiza-
tion procedure. Regarding the optimization algorithms, 3 alternatives are
provided:
• Evolutionary Algorithms (EAs) - for single objective;
• Simulated Annealing (SA) - for single objective;
• Strength Pareto Evolutionary Algorithm 2 (SPEA2) - for multiobjec-
tive.
Details of the algorithms’ implementations are available in Section 5.4
while their overall description can be found in Chapter 3 and in [2]. An API
class named StrainOptimizationControlCenter allows easy programmatic
access and fine tuning of every feature and parameter previously described.
This class can also be fully initialized using configuration files (described in
section 5.2.5).
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5.2.2 Solvers
The Solvers library implements an abstraction layer between generic prob-
lems, such as LP, MILP and QP problems (discussed in Chapter 2) and
specific formulations, such as FBA, MOMA, ROOM, etc. It provides a
complete portfolio of generic components (variables, constraints, objectives,
etc.) that can be combined to formulate any of the previously mentioned
methods. Furthermore, it also provides connectors that provide transparent
communication with various open source and commercial solvers/optimiz-
ers, including GLPK1, CLP2 and CPLEX3. When a phenotype prediction
for a given solution’s genotype is required from the Phenotype Prediction
package, the Solvers library is notified of changes in the formulations’ con-
straints (via environmental conditions, genetic conditions, etc) and reflects
those changes in its inner representation of the problem. Afterwards, the
solver optimizes the problem and returns a result (an array of values for each
of the problem’s variables). The Solvers library interprets this result, and
its variables’ values are translated into a flux distribution that represents
the final phenotype of the solution.
5.2.3 Jecoli3
The Java Evolutionary Computation Library (JECoLi 3) [8] is a generic
multi-purpose evolutionary computation library. It is an adaptable, flexi-
ble, extensible and reliable software framework implementing metaheuristic
optimization algorithms, using the Java programming language. In its cur-
rent version, JECoLi aims to offer a solution suited for the integration of
1http://www.gnu.org/software/glpk/glpk.html
2https://projects.coin-or.org/Clp
3http://www-01.ibm.com/software/commerce/optimization/cplex-optimizer/
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EC-based approaches in larger applications, as well as a way to the rapid
and efficient benchmarking of EC algorithms in specific problems taking
full advantage of the available hardware. Moreover, several metaheuristic
algorithms are provided: general purpose Evolutionary Algorithms, includ-
ing Genetic Algorithms (GAs) and Evolutionary Programming; Differential
Evolution; Genetic Programming (GP) and Linear GP; Simulated Anneal-
ing; Cellular Automata GAs [1] and multi-objective optimization Evolu-
tionary Algorithms (NSGA II and SPEA2). JECoLi 3 allows to encode
solutions using different types of representations such as: binary, integer,
real, permutations, sets and trees. JECoLi also provides a panoply of almost
40 reproduction operators (crossover and mutation) as well as several dis-
tinct selection operators implemented for EAs. A number of pre-processing
schemes applicable to the selection operators are also made available (e.g.
scaling, ranking). The library also includes an API that allows all its com-
ponents to be easily extended.
One the main features provided by Jecoli is the Archive Manager, a
facility capable of managing the solutions that are found by the algorithms
and providing a common layer between them. The Archive Manager runs in
parallel with the optimization algorithms and it is notified by the evaluation
functions. Each time a new solution is evaluated, the archive is notified
and decides whether or not to keep that solution. Several operations are
performed by the Archive Manager to maximize the number of interesting
solutions that are kept. The user is allowed to specify the maximum number
of solutions to keep, as well as the strategies to keep or remove solutions.
When multiple objective functions are defined, the archive manager uses
the Zitzler truncation method [9] to prune the archive to the maximum
allowed size.
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5.2.4 BioComponents
The BioComponents library includes API classes for reading and writing
metabolic models in several formats. An information abstraction layer
(Container) works as the pivot between the inputs and outputs, and it is
the connecting point for other software packages, such as the Metabolic3
library (Figure 5.2). All the available information is loaded into this Con-
tainer and can be either written to other standard formats or converted
to other datastructure. As an example, the Metabolic3 library uses a
ContainerConverter to extract a Model (which can include GPRs, Path-
ways, etc., depending on the information available in the original input).
Currently, the BioComponents library includes readers and writers for sev-
eral standard formats including the Systems Biology Markup Language
(SBML) [10], Metatool [11], Flat-files [1], BioOpt/BioMet [12] and a generic
table format (csv, tsv, etc.).
5.2.5 Tools for batch optimization and analysis
The requirement for large workflows of optimization and analysis proce-
dures, where the same methodologies would be repeated for various metabolic
models, several different carbon sources and alternative target compounds,
using multiple phenotype prediction methods and strain optimization algo-
rithms, led us to create a flexible batch optimization/analysis sub-framework
seamlessly integrated in the API. While this problem could have been solved
by hard-coding some scripts for each particular problem, we believed that
the ME community would lose a valuable research tool. These tools are
composed by three different components, the Configuration and Comman-
dLine Tools packages from the Metabolic3 library and the complementary
Algorithms and Tools for in silico Design of Cell Factories
172 | Chapter 5
MetabolicAnalysis library, whose dependency relationships are depicted in
Figure 5.4.
Metabolic3
Configuration
SmartProperties
Model
Configuration
Simulation 
Configuration
Optimization
Configuration
Cluster
Configuration
CommandLineTools
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Local
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Cluster
Runner
<<IAnalysisTask>>
AbstractRTask
AbstractRPlotTask
void readConfiguration()
AbstractRunner
readConfiguration()
aggregationByVariable()
AbstractTask
REnvironment
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CompileResults
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ScatterPlot
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BoxPlot
Histogram
MonotonicPlot
ParetoFrontPlot
3DParetoFrontPlot
Cluster
Generator
Local
Generator
Figure 5.4: The tools for batch optimization and analysis are composed by three
components. The Configuration and CommandLine tools from the Metabolic3 li-
brary and the MetabolicAnalysis library.
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Configuration
The Configuration package was developed from scratch in this work and
integrated with the core API components of the Metabolic3 library and
it acts as the mediator between the CommandLine Tools package and the
MetabolicAnalysis library. This package allows configurations for single or
multiple optimization procedures to be stored, executed and shared effort-
lessly. The package is composed of several hierarchically related classes as
depicted in Figure 5.4.
At the top of the hierarchy is the SmartProperties utility class. Any
configuration sub-class, whether it is a ModelConfiguration, a Simulation-
Configuration, an OptimizationConfiguration or a ClusterConfiguration,
is an extension of this class, thus inheriting all of its properties and features,
which include:
• Order awareness: - The class is fully aware of the ordering of the
properties therein contained, either by their in-memory declaration
time or by their position in the configuration file;
• Self awareness: - A configuration can refer to itself or to its current
directory using the reserved special variables ${THIS} and ${CDIR},
respectively.
• Properties inheritance: - A configuration instance can inherit
from another configuration instance, by using the special modifier
@DEPENDS;
• Variable declaration: - User defined variables can be declared by
using the special modifier $ followed by the desired variable name. De-
clared variables can be later accessed by using the modifier ${<VAR>}.
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All the system variables are also made available via the same modi-
fier. Multiple values can be assigned to a variable by separating them
with the delimiter |.
• Aliases declaration: - User defined aliases can be attributed to
variables’ assignments via the special modifier ~. This is useful for
referring to long or unorthodox variables’ assignments.
• Multiple states: - Using the special modifier @COMBINE, variables
can be combined.
A configuration can be declared to combine some or all of its variables,
thus possibly generating multiple states. This happens when a variable
possesses multiple assignments and is combined with other variables. A
configuration will have as many states as the number of possible unique
combinations generated by the multiply-assigned variables combined with
the @COMBINE modifier. An example configuration file and respective multi-
state tree, representing one of the optimization workflows used in Chapter 4,
is provided in Figure 5.5, where 5 variables are combined. In this example,
the ENV COND (environmental conditions) variable has 2 assignments - aero-
bic and anaerobic; the SUB (substrate) variable has 3 assignments - glucose,
xylose and glycerol; the PROD (target product) variable has 5 assignments
- succinate, lactate, pyruvate, glycerol and phenylalanine; the SIM (simu-
lation method) variable has 2 assignments - PFBA and LMOMA; and the
OPT ALG (optimization algorithm) variable has 3 assignments - EA, SA and
SPEA2. When we combine these 5 variables, a state tree is generated where
each state is represented by a path from the root to each of the leafs. In
this case, a total of 180 states/paths (2× 3× 5× 2× 3) are generated, each
representing a unique combination of each of the 5 variables. This facility
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provides a powerful and flexible tool to generate complex workflows where
multiple alternatives can be tested and summarized in a single file.
a)
b)
Root
aerobic
anaerobic
glucose
xylose
glycerol
succinate
lactate
phenylalanine
pyruvate
glycerol
PFBA
LMOMA
EA
SA
SPEA2
EA
SA
SPEA2
state 1
ENV_COND SUB PROD SIM OPT_ALG
2 3 5 2 3x x x x 180 states
3 states
3 states
24 states
60 states
90 states
+
+
+
+
=
=
Figure 5.5: Example of a configuration file (a) where 5 variables are combined,
some of which have multiple assignments. The tree of possible combinations is
displayed in b) with a particular state highlighted (state 1 - dotted purple area).
The ModelConfiguration, SimulationConfiguration, Optimization-
Configuration and ClusterConfiguration classes hierarchically extend
each other adding particular properties and API methods for their spe-
cific purposes. The ModelConfiguration is an extension of the basic con-
figuration class (SmartProperties) providing methods for declaring and
loading metabolic models. The SimulationConfiguration extends the
ModelConfiguration adding methods to declare and extract information
pertaining to the phenotype prediction methods, such as the method and
solver to use or the environmental conditions. Similarly, Optimization-
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Configuration extends the SimulationConfiguration, adding methods
to declare and configure the optimization algorithms and objective func-
tions of the problem. Finally, the ClusterConfiguration extends the
OptimizationConfiguration and adds methods to configure a computer
cluster or grid system, such as the job-scheduling system, submission queue
or memory and CPU requirements.
CommandLine Tools
The CommandLine Tools package contains API classes to work via the com-
mand line (5.4). In particular, the ClusterGenerator class can interpret a
ClusterConfiguration file, which contains all the model, simulation, op-
timization and cluster properties, and generate the appropriate scripts to
submit and execute in a cluster environment (the example in Figure 5.5 re-
flects the configuration of the search cluster4 used during this work intensive
optimization runs). An extra parameter can be provided defining the num-
ber of repetitions that each state must be executed (e.g. each experiment
can be repeated 30 times for statistical significance). The LocalGenerator
works in a similar way for environments without queue managers or job
scheduling systems (e.g. local systems).
This tool was used throughout this thesis, replacing traditional script-
ing strategies and allowing a simpler organization of all the configurations
and results, as well as making its computationally intensive nature more
amenable.
4http://search.di.uminho.pt
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MetabolicAnalysis
The MetabolicAnalysis library provides a set of analysis tasks that can be
executed over the results returned by the strain optimization algorithms.
This library was fully developed during the period of this thesis and it was
extensively useful for the processing and analysis of the results presented
so far. All the tasks extend the AbstractTask class that provides seamless
interaction with the Metabolic3 Configuration package (Figure 5.4).
Upon interpreting an optimization configuration, every task becomes
aware of all the possible optimization states (the various alternatives that
were executed), the number of repetitions for each state and the created
directory structure. Each task has a well defined set of inputs and outputs,
which can be combined in a black-box oriented fashion to design an analysis
workflow (Figure 5.6).
Task 1
input 1
input 2
output 1 Task 2
input 1
output 2
output 1
Task 3
input 1
input 2
output 1
Figure 5.6: Structure of a simple analysis workflow. Three tasks are depicted,
each declaring their expected inputs and outputs.
Each task verifies if its prerequisites are met and executes its procedure
for each declared configuration state, otherwise the user is informed of miss-
ing inputs. Furthermore, some tasks can use up to 3 variables aggregation,
to generate aggregated results for several states (e.g., a plotting task can
aggregate results for several algorithms and return a grid of plots).
Two distinct sets of tasks are provided, the first set is fully implemented
in Java (directly extends the AbstractTask) and include tasks such as: ag-
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gregation and simplification of optimization results (AggregateSimplify),
compilation of results (CompileResults, compilation of various metrics,
such as dominance metrics (ComputeMetrics) and extraction of non-dominated
sets (Non-dominated Set). The second one relies on a developed REnvironment
which provides a communication layer with the R language (AbstractRTask).
This environment is responsible for loading all the R dependencies and han-
dling bi-directional communication between R and Java. Such R-dependent
tasks include computation of statistics such as averages, means, standard-
deviations, etc (Statistics), frequencies (Frequencies) and multiple plots,
such as the venn-like plots presented in Chapter 4 (Venn), box-plots used in
Chapters 3 and 4 or the Pareto-front plots (ParetoFrontPlot and 3DPareto-
FrontPlot) exhibited in Chapter 3 (Figure 5.4).
5.3 Graphical User Interface Layer:
OptFlux
The GUI layer is provided by the OptFlux metabolic engineering workbench
[1]. The discussed optimization methods were seamlessly integrated in the
form of the optimization plug-in. OptFlux aims at being the reference
software platform for ME, providing an extensive set of tools for ME experts
with user-friendly interfaces.
It was the first tool to incorporate strain optimization tasks, i.e., the
identification of ME targets, using Evolutionary Algorithms/Simulated An-
nealing metaheuristics. It also allows the use of stoichiometric metabolic
models for prediction of wild-type and mutant organisms’ phenotypes, us-
ing FBA, pFBA, MOMA, LMOMA, ROOM and MiMBl. Furthermore, it
also incorporates Metabolic Flux Analysis (MFA), computing the admis-
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sible flux space given a set of measured fluxes, and support for pathway
analysis through the calculation of Elementary Flux Modes [13, 14].
OptFlux also provides access to several of the previously presented meth-
ods for model simplification, as well as pre-processing operations aimed at
reducing the search space for optimization algorithms. The workbench in-
cludes a visualization module that allows the analysis of the model structure
that is compatible with the multiple layout formats, allowing the superim-
position of simulation results with the model graph [15].
One of the major features of OptFlux is its modular architecture that
allows the easy integration of novel components. This is achieved thanks to
the framework on top of which OptFlux was build - AIBench [16]. AIBench
is a software development framework that was born as a collaborative
project between researchers from the University of Minho and researchers
from the University of Vigo, Spain. Building applications over AIBench
brings important advantages to both the developers and the users, given its
design principles and architecture. All the AIBench applications incorpo-
rate three types of well defined objects: operations, datatypes and views,
following the MVC (model-view-controller) design pattern as exemplified in
Figure 5.7.
Developing on top of AIBench forces the programmers to design highly
coherent applications, whose components can be easily combined and reused.
Additionally, AIBench includes a powerful plug-in engine: applications are
designed by plugging components (plug-ins), each of which contains a set
of AIBench objects. During the development of this work, the optimization
plug-in that ships in the base release of OptFlux was refactored to support
the features described in the previous chapters. Following the MVC design
pattern, several new components were added, from which the most relevant
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Operation (controller)
StrainOptimizationOperation
Datatype (model)
StrainOptimizationResultDatatype
Views
StrainOptimizationSummaryView
StrainOptimizationParetoView
<generates>
OptFlux 
User
StrainOptimizationOperationGUI
<updates>
<uses>
<invokes>
<sees>
Figure 5.7: A simple use case scenario for the a user interaction
with the StrainOptimization plug-in. The three main MVC compo-
nents and their AIBench counterparts are depicted: the user interacts
with the StrainOptimizationOperationGUI (a view) which invokes the
StrainOptimizationOperation (controller). The controller generates the
StrainOptimizationResultDatatype (model) which in turn updates the views.
will be detailed.
The StrainOptimizationOperationGUI provides a dialog for the Strain-
OptimizationOperation, which allows to the user to configure and launch
a strain optimization procedure. This dialog is depicted in Figure 5.8
This GUI allows setting up and configuring several optimization param-
eters:
• Select Simulation method: The method used to perform the phe-
notype simulation: FBA, pFBA, MOMA, LMOMA, ROOM and MiMBl
are available;
• Select Environmental Conditions: The list of available environ-
mental conditions for this project.
• Select the objective functions: OptFlux supports multiple-criteria
optimisation; this means that the user can select several objective
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Figure 5.8: Screenshot of the strain optimization configuration dialog.
functions to optimize at the same time, among the following: BPCY,
YIELD, Max/Min of reaction flux value, Max/Min of the number of
knockouts and Max/Min of the sum of flux measures. The user can
configure each objective function individually and add them to the
list (on the right);
• Select Optimization Algorithm: The optimization method to use,
selected from the available ones: EA, SA and SPEA2. SPEA2 is
natively multi-objective, thus prone to provide better solutions when
multiple objective functions are selected;
• Knockout Type: The user can select the strain optimization strat-
egy, by using reactions (R) or genes (G) as targets for deletion/knock-
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out (K) or over/under expression (OU);
• Optimization Basic Setup:
– Maximum Number of Solution Evaluations - The number of sim-
ulations allowed for this optimization. Increasing this parameter
will also increase the chances of finding optimal solutions, but
the optimization process will take more time to complete;
– Maximum Number of Knockouts - The maximum number of dele-
tions/regulations allowed;
– Variable size solution - When selected, the size of the solutions is
not fixed and can vary up to the maximum previously configured.
• Essential Information: Depending on whether the optimization
strategy is targeting reactions or genes, the user can select a set of
reactions/genes that will not be considered for deletion. This set can
be computed automatically by OptFlux or loaded from file.
During the optimization process, the user is presented with one of the
progress dialogs represented in Figure 5.9. These dialogs allow the user
to stop the optimization process when a desired result has been reached,
returning the results found thus far.
After the optimization process completes, the results (instances of the
StrainOptimizationResultsDatatype) are placed in the OptFlux results
clipboard. If the user selects this object, the views are launched. The two
available views for an optimization result are instances of the StrainOptimiza-
tionSummaryView and StrainOptimizationParetoView classes and they
fulfill two distinct objectives. The Strain Optimization Summary view, rep-
resented in Figure 5.10, provides a summarized overlook of the optimization
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(a) (b)
Figure 5.9: Screenshots of the progress dialogs presented to the user during op-
timization. When a single objective function is selected the x-axis represents the
number of function evaluations and the y-axis the objective function, resulting in
a convergence plot (a). When multiple objective functions are selected both axis
are used to represent objective functions (which can be interchangeable), resulting
in a pareto plot (b).
execution and configuration, including its time of creation, execution time,
number of solutions found during optimization and after post-processing
(simplification). It also keeps information about the phenotype predic-
tion method used, environmental conditions, optimization algorithm and
respective configurations, as well as the objective functions and the set of
critical information (essentiality). This allows the users to know exactly
how and when those results were generated since multiple optimizations
can be stored in the clipboard.
The second view, the Strain Optimization Results view, depicted in Fig-
ure 5.11 is where the solutions found during the optimization process are
displayed. The view is segmented into three areas. At the top, a list with
all the solutions is presented where, for each solution, a solution id and
the values for each of the used objective functions are displayed. This list
has search, sort (by each column) and export capabilities. Directly below
the solutions list, a button (”Add to simulation results”) allows the user
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Figure 5.10: Screenshot of the strain optimization summary view.
to send one or multiple selected solutions to the clipboard as independent
simulation results to be further analyzed or visualized in detail. When a
solution is selected the genetic modifications that compose that solution are
displayed in the bottom-left area. Knockouts are represent by < id >= 0.0
where < id > can be either a gene or a reaction identifier, and over/under
expressions are represented by < id >=< value >, where < value > is the
number of fold-increases or decreases of that gene expression/reaction value
relatively to their reference value (usually from a wild-type simulation).
The bottom-right area is a plot where each solution is represented by
their objective function values. This plot allows the user to have a general
overview of the success of the optimization procedure, as well as to dis-
criminate between multiple solutions. As an example, a user can opt for
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Figure 5.11: Screenshot of the strain optimization results view.
trading-off a solution with a higher production of the desired compound for
another with more biomass or one which has less knockouts. Furthermore,
the plot is fully interactive, allowing the users to select the solutions directly
from it, switching the objective functions represented in each axis, zooming
in/out and even exporting the plot to a portable image format.
5.4 Detailed Methods
During this thesis and in particular in Chapter 3, several algorithms were
introduced but not explored extensively. In this section, the algorithmic
details and particular features of some of those algorithms will be presented
and discussed.
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5.4.1 Strength Pareto Evolutionary Algorithm 2
(SPEA2)
Main Loop
The overall algorithm main loop is defined in Algorithm 1.
Algorithm 1 The SPEA2 main loop
1: Input:
N {population size}
N¯ {archive size}
E {maximum number of evaluations}
2: Output:
A {nondominated set}
3: Step 1 - Initialization:
4: P0 {randomly generate an initial population}
5: P¯0 = ∅ {create the empty archive (external set)}
6: Set e = 0 {initialize evaluation counter}
7: Step 2:
8: evaluatePhenotypes(Pe) {Phenotype Evaluation}
9: fit(Pe) and fit(P¯e) {Calculate fitness values of solutions in Pe
and P¯e. See 5.4.1}
.
10: Ue ← union(Pe,P¯e) {Calculate multi-set union between popula-
tion and archive}
11: Step 3 - Environmental Selection: Copy all nondominated individ-
uals in Ue to P¯e+1. If size of P¯e+1 exceeds N¯ then reduce P¯e+1 by means
of the truncation operator, otherwise if size of P¯e+1 is less than N¯ then
fill P¯e+1 with dominated individuals from Pe and P¯e.
12: Step 4 - Termination: if e ≥ E or another stopping criterion is
satisfied, then set A to the set of decision variables represented by the
nondominated in P¯e+1 and stop. Otherwise, proceed to step 5.
13: Step 5 - Mating Selection: Perform binary tournament selection
with replacement on P¯e+1 to fill the mating pool
14: Step 6 - Variation: Apply recombination and mutation operators to
the pool and set P¯e+1 to the resulting population. Increment evaluation
counter (e = e+ |Pe|). Go to Step 2.
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In SPEA2, individuals that are dominated by the same archive members
have identical fitness values. This means that in the case when the archive
contains only a single individual, all population members have the same
rank independently of whether they dominate each other or not. As a
consequence, the selection pressure is decreased substantially and, in this
particular case, the SPEA behaves like a random search algorithm. To
avoid this, in SPEA2, for each individual both dominating and dominated
solutions are taken into account.
Fitness assignment
Each individual i is assigned a strength value Si representing the number
of solutions it dominates:
S(i) = |j : j ∈ Pt ∪ P¯t ∧ i ≺ j| (5.1)
where |.| is the cardinality of the set, Pt is the current population, P¯t the cur-
rent archive,
⋃
stands for multiset union and ≺ corresponds to the Pareto
dominance relation. The raw fitness R(i) of an individual i is calculated:
R(i) =
∑
j∈Pt∪P¯t,j≺i
S(j) (5.2)
The raw fitness alone is not robust when most individuals do not domi-
nate each other. Additional density information is then added to discrimi-
nate between individuals with identical raw fitness values. Density is defined
as:
D(i) =
1
σki + 2
(5.3)
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where σki is the distance of the individual i to k, and k=
√
N + N¯ , with
N and N¯ being the size of the population and the archive, respectively.
Finally, the final fitness of the individual i is calculated as:
F (i) = R(i) +D(i) (5.4)
Density Estimation and Archive Truncation
If many individuals of the current generation are indifferent, i.e., do not
dominate each other, none or very little information can be obtained on the
basis of the ordering defined by the dominance relation. In this situation,
which is very likely to occur in the presence of more than two objectives,
density information has to be used in order to guide the search more effec-
tively. Clustering makes use of this information, but only with regard to
the archive and not to the population.
The SPEA2 algorithm is able to reduce the nondominated set without
losing its characterists via the clustering technique previously mentioned,
however, to avoid losing outer solutions an archive truncation method that
preserves these, is also contemplated. More details about these two proce-
dures can be found in [9].
Environmental Selection
There are two main differences between the archive update operation be-
tween SPEA and SPEA2: the first is that the number of individuals in the
archive is constant over time; the second regards the truncation method
that prevents boundary solutions from being removed. The first step is to
copy all nondominated individuals from the archive and the population to
the next generation:
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P¯t+1 = {i : (i ∈ Pt ∪ P¯t ∧ F (i) < 1)} (5.5)
If the nondominated front fits the archive (|P¯t+1| = N¯), the environmen-
tal selection step is completed. Otherwise, either the archive is too small
or too large. If the archive is too small, the best N¯ − |P¯t+1| dominated
individuals in the previous archive and population are copied to the new
archive. In the second case, the archive truncation procedure is applied
until the archive size is equal to N¯ .
5.4.2 Evolutionary Algorithm (EA)
The EA main loop is defined in Algorithm 2. Further details can be found
in [2].
Algorithm 2 The EA main loop
1: Input:
N {population size}
Nr {number of replacements per generation}
E {maximum number of evaluations}
2: Output:
PE {final population, i.e., when e=E}
3: Initialization:
Randomly generate an initial population P0;
e← 0 {set evaluation counter to 0}
evaluatePhenotypes(P0)
4: while (e ≤ E) do
5: Par = [Par0, . . . , Parn]← Pe {select parents}
6: Pe ← recombine(Par) {apply recombination to generate offspring}
7: Pe ← mutate(Pe) {apply mutation}
8: evaluatePhenotypes(Pe)
9: Pe+1 ← selection(Pe) {select individuals for the next generation}
10: e← e+Nr. {increase counter by the number of new solutions}
11: end while
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5.4.3 Simulated Annealing (SA)
The SA main loop is defined in algorithm 3. Further details can be found
in [2].
Algorithm 3 The SA main loop (assuming maximization)
1: Input:
E {maximum number of evaluations}
TpT {number of trials per temperature}
∆i {allowed initial delta}
∆f {allowed final delta}
2: Output:
SE {final solution, i.e., when e=E}
3: Initialization:
e← 0 {set evaluation counter to 0}
{α, Te} ← initializeAnnealingSchedule(∆i,∆f )
S0 {generate an initial solution}
FS0 ← evaluateSolution(S0) {evaluate initial solution fitness}
4: while (e ≤ E) do
5: for (trial = 0→ TpT ) do
6: Strial ← mutate(Se) {create trial solution via mutation}
7: FStrial ← evaluateSolution(Strial) {evaluate trial solution}
8: if (FStrial ≥ FSe) then
9: Se ← Strial {move to new solution}
10: else
11: rnd← [0..1] {create random number in range}
12: boltz ← e fit(Strial)−fit(Se)Te {accept. prob. via Boltzmann factor}
13: if (rnd < boltz) then
14: Se ← Strial {move to new solution}
15: end if
16: end if
17: trial← trial + 1
18: end for
19: Te ← Te ∗ α {update current temperature}
20: e← e+ TpT {increase evaluation counter}
21: end while
The Annealing Schedule initialization (4) is used to compute the initial
temperature as well as the cooling schedule. This is done using the ∆i and
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∆f , user variables that are usually based on the fitness landscape of the
problem.
Algorithm 4 initializeAnnealingSchedule(∆i,∆f )
1: T0 ← −∆ilog(0.5) {initial temperature}
2: Tmin ← −∆flog(0.5) {minimum temperature}
3: #Tvar ← ETpT {total number of temperature variations}
4: α← e
log(
Tmin
T0
)
#Tvar {alpha factor}
5: e: Te ← T0 {current temperature}
6: return {α, Te}
5.4.4 Phenotype Evaluation
The phenotype evaluation modules are responsible to decode the candidate
solutions into valid constraints of the model, apply the phenotype simula-
tion methods (FBA, MOMA or ROOM) and, from the resulting flux distri-
bution, compute the fitness or fitnesses for the selected objective functions.
The evaluation procedure also notifies the Archive Manager that a solution
or a population of solutions has been evaluated, allowing this to either keep
that solution or execute a series of maintenance procedures (truncation,
sorting, storing). This is detailed in algorithms 5 and 6.
Algorithm 5 evaluatePhenotypes(P )
1: for all S ∈ P do
2: FS ← evaluateSolution(S) {Evaluate the solution S and set its fitness
array FS.}
3: end for
4: notifyArchive(P ) {notify the archive manager that a population
has been evaluated}
It should be noted that the archive manager is created separately, re-
gardless of the optimization algorithm (including SPEA2 that uses its own
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Algorithm 6 evaluateSolution(S)
1: Inputs:
M {stoichiometric model}
OF {array of objective functions}
2: C ← S {compute override constraints from solution}
3: Mc ← apply(C,M) {stoichiometric model w/override constraints}
4: FD ← fluxDistribution(Mc) {flux distribution computation using one
of the available methods: FBA, MOMA,
ROOM }
5: F ← ∅ {create empty fitness array of size |OF |}
6: for (i = 0; i < |OF |; i← i+ 1) do
7: objFunc← OFi
8: Fi ← objFunc(FD) {apply objective function to flux distribution}
9: end for
10: notifyArchive(S) {notify the archive manager that a solution
has been evaluated}
11: return: F
Algorithm 7 notifyArchive(S)
1: Inputs:
A {the global archive}
2: sub← existsSubSB(A, S) {verifies if there exists a subset, better solu-
tion than S in A}
3: if (¬sub) then
4: SnB ← existsSuperSNB(A, S)
5: remove(SnB,A) {remove all superset non better solutions
from the archive}
6: add(S,A) {if not, adds the solution to the global archive}
7: end if
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internal archive). This allows to keep solutions using the dominance prop-
erties natural to MO algorithms, even when an SO algorithm is selected.
Details are presented in algorithms 7 and 8.
Algorithm 8 notifyArchive(P )
1: Inputs:
2: A {the global archive}
3: processArchive(A)
4: applyTruncation(A) {Apply truncation based on dominance. See
??}
5: sort(A)
6: store(A)
5.5 Implementation and Availability
The framework was fully developed in the Java programming language with
the exception of the MetabolicAnalysis library that was developed in both
Java and R (installation of R v3.0.2 or superior is mandatory). OptFlux
can be downloaded from www.optflux.org. All the code is readily available
in the project sourceforge page at sourceforge.net/projects/optflux/.
5.6 Conclusions
This work proposes an integrated framework that allows its users to con-
figure and fine tune strain optimization strategies tailored to their specific
needs. The framework is segmented in two layers, allowing both experienced
programmers and regular users to take advantage of the methods developed
during this thesis, as well as easily extend them to support new features.
The integration of this framework in the open-source OptFlux platform,
makes it an attractive resource to an ever increasing ME community.
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Future work contemplates the generalization of the optimization layer
to support some of the other CSOMs discussed in this thesis (Chapter 2),
as well as the improvement of the programming interfaces making it even
easier to extend the framework with third-party software.
Paulo Maia University of Minho, 2015
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chapter 6
CONCLUSIONS AND FUTURE WORK
In this chapter, a summary of the main findings and contributions of this
thesis is presented. Some general conclusions are drawn and topics for
future work are suggested.
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6.1 General Conclusions
The main objective of this thesis was the development of new algorithms
and tools for in silico optimization of mutant strains for industrial biotech-
nology applications. The work began by a thorough assessment of the
state-of-the-art of the field, performing a comprehensive analysis of the ma-
jor CSOMs developed in recent years. These methods were classified into
three groups, according to their most prominent characteristics, an anal-
ysis of their successful applications in vivo was devised and their level of
adoption by the industry was scrutinized.
We concluded that, despite successful in vivo applications, the obtained
improvements in yields, productivities and titers are still far away from
the ones obtained with non-rational traditional approaches such as random
mutagenesis. While we clearly attribute some of these shortcomings to the
lack of relevant information in the models, a lack of validation efforts of the
current methods was also detected. In fact, since most of the few validation
efforts have been reported associated with specific CSOMs, which would be
the final layer of an in silico approach, it is often impossible to decouple
the effects of model predictions from the CSOM results themselves. More
studies are thus needed that would allow to the separate the validation
of GSMMs, simulation tools and CSOMs. Only to mention an extreme
example, the validation of simulation methods such as FBA, MOMA or
ROOM in a large scale has never been performed apart from the examples
used when the methods have been developed or improved, a gap attributable
in part to the scarcity of flux distribution experimental data.
In summary, although improvements are clearly needed in the develop-
ment of novel CSOMs, that were very scarce until recently, it is probably
also important to focus research efforts on the experimental validation of
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in silico approaches to foster the adoption of rational tools in industrial
biotechnology.
Another limitation that we identified with current CSOMs was that
they usually return a single solution to the problem or, in some cases, sets
of solutions with limited variability. We began addressing that problem by
proposing an evolutionary multi-objective framework for strain optimiza-
tion (MOStrain). The developed framework was tested for the in silico
production of succinate, lactate and pyruvate using a recent GSMM of Es-
cherichia coli with promising results. One of the main advantages of the
proposed method is the ability of specifying multiple objective functions,
providing, in a single run, a set of alternative, high-quality, trade-off solu-
tions that can be explored by ME experts.
Leveraging on the developed multi-objective framework, we addressed
another common limitation of the current methods, their dependence on the
used phenotype prediction method. The majority of the CSOMs, excluding
the ones based in pathway analysis, encode some form of phenotype predic-
tion method in their formulations, which in turn were built on top of a given
biological assumption. We verified that, for a large percentage of solutions
generated by a CSOM using one phenotype prediction method, the results
would not hold when simulated with an alternative method. There is still a
heated debate concerning the behaviour of a microorganism when subjected
to some form of perturbation. Supported by the recent work of Schuetz and
co-workers [1], where they claimed that the metabolism of bacteria operates
close to the Pareto-optimal surface of a three-dimensional space defined by
competing objectives, demonstrating the validity of their claims for various
environmental perturbations, we argued that the same principle could be
applied to genetic perturbations. We proposed a tandem approach capable
Paulo Maia University of Minho, 2015
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of finding strain designs that comply with the assumptions of multiple phe-
notype prediction methods, and validated the approach with an array of
case studies, using pFBA and LMOMA as phenotype prediction methods.
Finally, we provided all the software and tools developed throughout
this work in the form of a well-designed, and flexible framework. This
framework reaches both common users with no programming background,
able to access a large range of the features via the developed OptFlux plug-
in, and experienced programmers which are able to use all the included
features, or extend it with new ones.
6.2 Topics for Future Work
The methods developed during this thesis provide a valuable contribution to
the state of the art of the area. Notwithstanding, some interesting follow-up
alternatives can be explored:
• During the thesis, only strategies based on gene deletions were ex-
plored. The application of the developed framework to other types
of strain optimization tasks, such as, heterologous gene insertion [2],
co-factor specificity modulation [3] and gene over/under expression [4]
could be valuable alternatives.
• One of the under-explored aspects of this work concerns the limited
range of objective functions and phenotype prediction methods that
were effectively explored. In particular the application of the tandem
approaches using alternative methods such as ROOM and MiMBl is
of particular interest.
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• Another area where big developments could be achieved, is in com-
bining the scalability advantages of meta-heuristics with the unbiased
characterization of the metabolic space provided by pathway analysis
approaches.
• From a software development perspective, an ongoing objective is the
generalization of the developed framework to allow the inclusion other
types of CSOMS not based on meta-heuristics.
Paulo Maia University of Minho, 2015
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